"","T4.1","T4.10","T4.16","T4.17","T4.6","T4.8","T5.1","T5.10","T5.16","T5.17","T5.6","T5.8","T7.1","T7.10","T7.16","T7.17","T7.6","T7.8","gene","Uniprot","eval","Prot.ID","Rev","Prot.Name.Long","Prot.Name.Short","Taxa","Num","GO1","GO2","GO3","GO4","GO.IDs","KEGG","KEGG.Path"
"1",317,499,673,593,327,287,482,602,725,488,733,447,879,794,962,437,775,725,"g22366","P45953",0,"ACADV_RAT","reviewed","Very long-chain specific acyl-CoA dehydrogenase, mitochondrial (VLCAD) (EC 1.3.8.9)","Acadvl Vlcad","Rattus norvegicus (Rat)",655,"epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty acid catabolic process [GO:0009062]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; regulation of cholesterol metabolic process [GO:0090181]; response to cold [GO:0009409]; temperature homeostasis [GO:0001659]","mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]","mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty acid catabolic process [GO:0009062]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; regulation of cholesterol metabolic process [GO:0090181]; response to cold [GO:0009409]; temperature homeostasis [GO:0001659]","acyl-CoA dehydrogenase activity [GO:0003995]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]","GO:0000062; GO:0001659; GO:0003995; GO:0004466; GO:0005739; GO:0005743; GO:0006635; GO:0009062; GO:0009409; GO:0017099; GO:0030855; GO:0031966; GO:0033539; GO:0042645; GO:0045717; GO:0046322; GO:0050660; GO:0090181","K09479;","rno:25363;"
"2",128,182,196,186,99,119,159,213,288,194,175,239,249,310,314,156,272,281,"g22542","P02594",2.47e-64,"CALM_ELEEL","reviewed","Calmodulin (CaM)","calm","Electrophorus electricus (Electric eel) (Gymnotus electricus)",149,"calcium-mediated signaling [GO:0019722]","","calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]","calcium ion binding [GO:0005509]","GO:0005509; GO:0019722","",""
"3",108,35,61,87,91,29,74,70,69,111,148,55,122,54,80,42,167,39,"g22955","Q09694",1.02e-118,"LYS1_SCHPO","reviewed","Saccharopine dehydrogenase [NAD(+), L-lysine-forming] (SDH) (EC 1.5.1.7) (Lysine--2-oxoglutarate reductase)","lys3 SPAC227.18 SPAC2F7.01","Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)",368,"lysine biosynthetic process [GO:0009085]; lysine biosynthetic process via aminoadipic acid [GO:0019878]","cytoplasm [GO:0005737]","cytoplasm [GO:0005737]; saccharopine dehydrogenase (NAD+, L-lysine-forming) activity [GO:0004754]; lysine biosynthetic process [GO:0009085]; lysine biosynthetic process via aminoadipic acid [GO:0019878]","saccharopine dehydrogenase (NAD+, L-lysine-forming) activity [GO:0004754]","GO:0004754; GO:0005737; GO:0009085; GO:0019878","K00290;","spo:SPAC227.18;"
"4",285,572,1289,726,447,289,170,1754,1637,485,919,745,7208,2187,4971,367,1250,3344,"g23756","Q86WI1",0,"PKHL1_HUMAN","reviewed","Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1)","PKHD1L1","Homo sapiens (Human)",4243,"immune response [GO:0006955]","cilium [GO:0005929]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]","cilium [GO:0005929]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; signaling receptor activity [GO:0038023]; immune response [GO:0006955]","signaling receptor activity [GO:0038023]","GO:0005615; GO:0005829; GO:0005929; GO:0006955; GO:0016021; GO:0038023","","hsa:93035;"
"5",40,56,95,59,32,13,16,75,114,41,46,52,10,57,76,12,13,50,"g24187","Q99056",6.71e-52,"LAC5_TRAVI","reviewed","Laccase-5 (EC 1.10.3.2) (Benzenediol:oxygen oxidoreductase 5) (Diphenol oxidase 5) (Urishiol oxidase 5)","LCC5","Trametes villosa (White-rot fungus)",527,"lignin catabolic process [GO:0046274]","extracellular region [GO:0005576]","extracellular region [GO:0005576]; copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]; lignin catabolic process [GO:0046274]","copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]","GO:0005507; GO:0005576; GO:0046274; GO:0052716","",""
"6",388,351,429,527,404,217,285,413,317,318,426,188,360,252,336,276,478,175,"g25232","Q921L8",0,"GLT11_MOUSE","reviewed","Polypeptide N-acetylgalactosaminyltransferase 11 (EC 2.4.1.41) (Polypeptide GalNAc transferase 11) (GalNAc-T11) (pp-GaNTase 11) (Protein-UDP acetylgalactosaminyltransferase 11) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 11)","Galnt11","Mus musculus (Mouse)",608,"cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; Notch receptor processing [GO:0007220]; Notch signaling involved in heart development [GO:0061314]; protein O-linked glycosylation via threonine [GO:0018243]; regulation of Notch signaling pathway [GO:0008593]","Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]","Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; Notch binding [GO:0005112]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; Notch receptor processing [GO:0007220]; Notch signaling involved in heart development [GO:0061314]; protein O-linked glycosylation via threonine [GO:0018243]; regulation of Notch signaling pathway [GO:0008593]","carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; Notch binding [GO:0005112]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]","GO:0000139; GO:0004653; GO:0005112; GO:0005794; GO:0007220; GO:0007368; GO:0008593; GO:0016021; GO:0018243; GO:0030246; GO:0046872; GO:0060271; GO:0061314","K00710;","mmu:231050;"
"7",467,887,1089,646,555,808,44,595,414,546,428,590,91,88,240,99,120,236,"g25294","P57788",2.81e-40,"MOT4_CHICK","reviewed","Monocarboxylate transporter 4 (MCT 4) (Solute carrier family 16 member 3)","SLC16A3 MCT4","Gallus gallus (Chicken)",473,"monocarboxylic acid transport [GO:0015718]","integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]","integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]","lactate transmembrane transporter activity [GO:0015129]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]","GO:0005887; GO:0008028; GO:0015129; GO:0015293; GO:0015718; GO:0016021","K08180;","gga:395383;"
"8",687,865,1519,1011,816,879,92,622,519,931,724,673,127,82,319,102,134,254,"g25295","P57788",1.18e-40,"MOT4_CHICK","reviewed","Monocarboxylate transporter 4 (MCT 4) (Solute carrier family 16 member 3)","SLC16A3 MCT4","Gallus gallus (Chicken)",473,"monocarboxylic acid transport [GO:0015718]","integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]","integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]","lactate transmembrane transporter activity [GO:0015129]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]","GO:0005887; GO:0008028; GO:0015129; GO:0015293; GO:0015718; GO:0016021","K08180;","gga:395383;"
"9",51,52,83,64,40,30,105,92,126,80,107,86,133,77,87,52,133,57,"g25809","P50549",2.48e-66,"ETV1_HUMAN","reviewed","ETS translocation variant 1 (Ets-related protein 81)","ETV1 ER81","Homo sapiens (Human)",477,"axon guidance [GO:0007411]; cell differentiation [GO:0030154]; mechanosensory behavior [GO:0007638]; muscle organ development [GO:0007517]; peripheral nervous system neuron development [GO:0048935]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]","nuclear chromatin [GO:0000790]; nucleus [GO:0005634]","nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; mechanosensory behavior [GO:0007638]; muscle organ development [GO:0007517]; peripheral nervous system neuron development [GO:0048935]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]","DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]","GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0006366; GO:0007411; GO:0007517; GO:0007638; GO:0030154; GO:0045944; GO:0048935","K09431;","hsa:2115;"
"10",44,41,176,45,28,78,25,61,122,44,26,87,23,167,364,23,51,174,"g25830",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"11",21,10,43,42,11,25,24,150,110,71,120,133,85,57,62,49,88,101,"g25991",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"12",362,665,665,364,353,366,202,1023,748,513,788,588,873,1809,1967,470,920,1421,"g27090","Q9WU63",8.05e-41,"HEBP2_MOUSE","reviewed","Heme-binding protein 2 (Protein SOUL)","Hebp2 Soul","Mus musculus (Mouse)",205,"negative regulation of mitochondrial membrane potential [GO:0010917]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of necrotic cell death [GO:0010940]","cytoplasm [GO:0005737]; mitochondrion [GO:0005739]","cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; heme binding [GO:0020037]; negative regulation of mitochondrial membrane potential [GO:0010917]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of necrotic cell death [GO:0010940]","heme binding [GO:0020037]","GO:0005737; GO:0005739; GO:0010917; GO:0010940; GO:0020037; GO:0035794","","mmu:56016;"
"13",913,248,815,224,203,245,59,104,147,75,162,37,45,50,97,18,42,35,"g27092","Q9Y5Z4",4.46e-27,"HEBP2_HUMAN","reviewed","Heme-binding protein 2 (Placental protein 23) (PP23) (Protein SOUL)","HEBP2 C6orf34 SOUL","Homo sapiens (Human)",205,"negative regulation of mitochondrial membrane potential [GO:0010917]; neutrophil degranulation [GO:0043312]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of necrotic cell death [GO:0010940]","azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]","azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; heme binding [GO:0020037]; negative regulation of mitochondrial membrane potential [GO:0010917]; neutrophil degranulation [GO:0043312]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of necrotic cell death [GO:0010940]","heme binding [GO:0020037]","GO:0005576; GO:0005737; GO:0005739; GO:0010917; GO:0010940; GO:0020037; GO:0035578; GO:0035794; GO:0043312; GO:0070062","","hsa:23593;"
"14",22,18,8,8,12,23,18,22,13,7,16,14,22,0,0,7,8,0,"g27244","P24044",1.4e-51,"CALM_PLAFA","reviewed","Calmodulin (CaM)","","Plasmodium falciparum",149,"calcium-mediated signaling [GO:0019722]","","calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]","calcium ion binding [GO:0005509]","GO:0005509; GO:0019722","",""
"15",204,210,329,209,154,88,52,468,211,283,242,174,2005,504,2257,193,652,593,"g27639","P12394",7.37e-134,"CP17A_CHICK","reviewed","Steroid 17-alpha-hydroxylase/17,20 lyase (EC 1.14.14.19) (EC 1.14.14.32) (17-alpha-hydroxyprogesterone aldolase) (CYPXVII) (Cytochrome P450 17A1) (Cytochrome P450-C17) (Cytochrome P450c17)","CYP17A1 CYP17","Gallus gallus (Chicken)",508,"hormone biosynthetic process [GO:0042446]; progesterone metabolic process [GO:0042448]; sex differentiation [GO:0007548]; steroid biosynthetic process [GO:0006694]; steroid metabolic process [GO:0008202]","membrane [GO:0016020]","membrane [GO:0016020]; 17-alpha-hydroxyprogesterone aldolase activity [GO:0047442]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508]; hormone biosynthetic process [GO:0042446]; progesterone metabolic process [GO:0042448]; sex differentiation [GO:0007548]; steroid biosynthetic process [GO:0006694]; steroid metabolic process [GO:0008202]","17-alpha-hydroxyprogesterone aldolase activity [GO:0047442]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508]","GO:0004508; GO:0005506; GO:0006694; GO:0007548; GO:0008202; GO:0016020; GO:0020037; GO:0042446; GO:0042448; GO:0047442","K00512;","gga:425056;"
"16",11,30,40,33,20,32,111,126,102,19,201,198,321,195,224,25,105,212,"g27780",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"17",1829,1589,4348,3307,1556,950,699,2809,3032,2206,1812,1219,530,419,1213,286,575,584,"g30027","Q6ZZY0",0,"CRY1_SYLBO","reviewed","Cryptochrome-1","CRY1","Sylvia borin (Garden warbler)",620,"circadian rhythm [GO:0007623]; negative regulation of gluconeogenesis [GO:0045721]; protein-chromophore linkage [GO:0018298]; response to light stimulus [GO:0009416]","cytosol [GO:0005829]; nucleus [GO:0005634]; photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment membrane [GO:0042622]","cytosol [GO:0005829]; nucleus [GO:0005634]; photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment membrane [GO:0042622]; nucleotide binding [GO:0000166]; photoreceptor activity [GO:0009881]; circadian rhythm [GO:0007623]; negative regulation of gluconeogenesis [GO:0045721]; protein-chromophore linkage [GO:0018298]; response to light stimulus [GO:0009416]","nucleotide binding [GO:0000166]; photoreceptor activity [GO:0009881]","GO:0000166; GO:0005634; GO:0005829; GO:0007623; GO:0009416; GO:0009881; GO:0018298; GO:0042622; GO:0045721; GO:0097381","",""
"18",1604,1184,2388,2491,1361,1776,419,1227,972,985,946,995,198,189,437,159,306,214,"g30029","Q49AN0",4.01e-117,"CRY2_HUMAN","reviewed","Cryptochrome-2","CRY2 KIAA0658","Homo sapiens (Human)",593,"blue light signaling pathway [GO:0009785]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; glucose homeostasis [GO:0042593]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; regulation of sodium-dependent phosphate transport [GO:2000118]; response to activity [GO:0014823]; response to light stimulus [GO:0009416]","cytosol [GO:0005829]; extracellular region [GO:0005576]; nuclear speck [GO:0016607]; nucleus [GO:0005634]","cytosol [GO:0005829]; extracellular region [GO:0005576]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; blue light photoreceptor activity [GO:0009882]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; phosphatase binding [GO:0019902]; single-stranded DNA binding [GO:0003697]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; blue light signaling pathway [GO:0009785]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; glucose homeostasis [GO:0042593]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; regulation of sodium-dependent phosphate transport [GO:2000118]; response to activity [GO:0014823]; response to light stimulus [GO:0009416]","blue light photoreceptor activity [GO:0009882]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; phosphatase binding [GO:0019902]; single-stranded DNA binding [GO:0003697]; transcription regulatory region sequence-specific DNA binding [GO:0000976]","GO:0000122; GO:0000976; GO:0003677; GO:0003684; GO:0003697; GO:0005576; GO:0005634; GO:0005829; GO:0007623; GO:0009416; GO:0009785; GO:0009882; GO:0014823; GO:0016607; GO:0018298; GO:0019902; GO:0032515; GO:0032922; GO:0042593; GO:0042752; GO:0042754; GO:0043153; GO:0045892; GO:0071949; GO:2000118; GO:2000323","K02295;","hsa:1408;"
"19",246,209,388,419,214,82,82,174,115,135,168,197,7,18,60,16,51,47,"g30030","Q32Q86",1.23e-65,"CRY1_RAT","reviewed","Cryptochrome-1","Cry1","Rattus norvegicus (Rat)",588,"circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA damage induced protein phosphorylation [GO:0006975]; entrainment of circadian clock by photoperiod [GO:0043153]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; lipid storage [GO:0019915]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of glucocorticoid secretion [GO:2000850]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein ubiquitination [GO:0031398]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; regulation of DNA damage checkpoint [GO:2000001]; response to activity [GO:0014823]; response to glucagon [GO:0033762]; response to insulin [GO:0032868]; response to light stimulus [GO:0009416]","mitochondrion [GO:0005739]; nucleus [GO:0005634]","mitochondrion [GO:0005739]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; E-box binding [GO:0070888]; histone deacetylase binding [GO:0042826]; kinase binding [GO:0019900]; nuclear hormone receptor binding [GO:0035257]; nucleotide binding [GO:0000166]; phosphatase binding [GO:0019902]; photoreceptor activity [GO:0009881]; protein kinase binding [GO:0019901]; transcription factor binding [GO:0008134]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA damage induced protein phosphorylation [GO:0006975]; entrainment of circadian clock by photoperiod [GO:0043153]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; lipid storage [GO:0019915]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of glucocorticoid secretion [GO:2000850]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of protein ubiquitination [GO:0031398]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; regulation of DNA damage checkpoint [GO:2000001]; response to activity [GO:0014823]; response to glucagon [GO:0033762]; response to insulin [GO:0032868]; response to light stimulus [GO:0009416]","double-stranded DNA binding [GO:0003690]; E-box binding [GO:0070888]; histone deacetylase binding [GO:0042826]; kinase binding [GO:0019900]; nuclear hormone receptor binding [GO:0035257]; nucleotide binding [GO:0000166]; phosphatase binding [GO:0019902]; photoreceptor activity [GO:0009881]; protein kinase binding [GO:0019901]; transcription factor binding [GO:0008134]","GO:0000122; GO:0000166; GO:0003690; GO:0005634; GO:0005739; GO:0006094; GO:0006975; GO:0007623; GO:0008134; GO:0009416; GO:0009881; GO:0014823; GO:0018298; GO:0019900; GO:0019901; GO:0019902; GO:0019915; GO:0031397; GO:0031398; GO:0032868; GO:0032922; GO:0033762; GO:0035257; GO:0042593; GO:0042752; GO:0042754; GO:0042826; GO:0043153; GO:0045721; GO:0045744; GO:0045892; GO:0070888; GO:2000001; GO:2000323; GO:2000850","K02295;","rno:299691;"
"20",16,53,25,29,37,22,18,98,28,70,66,71,282,281,217,69,132,200,"g30156","Q29RZ5",7.36e-61,"TNG2_BOVIN","reviewed","Transport and Golgi organization protein 2 homolog","TANGO2","Bos taurus (Bovine)",276,"Golgi organization [GO:0007030]; protein secretion [GO:0009306]","Golgi apparatus [GO:0005794]","Golgi apparatus [GO:0005794]; Golgi organization [GO:0007030]; protein secretion [GO:0009306]","","GO:0005794; GO:0007030; GO:0009306","","bta:518209;"
"21",1289,1177,1883,1549,1122,1066,873,1588,1693,1159,1467,1242,1583,1430,2034,862,1819,1674,"g30299","Q2YDQ5",1.27e-77,"FBXL5_DANRE","reviewed","F-box/LRR-repeat protein 5 (F-box and leucine-rich repeat protein 5)","fbxl5","Danio rerio (Zebrafish) (Brachydanio rerio)",679,"iron ion homeostasis [GO:0055072]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]","perinuclear region of cytoplasm [GO:0048471]; SCF ubiquitin ligase complex [GO:0019005]","perinuclear region of cytoplasm [GO:0048471]; SCF ubiquitin ligase complex [GO:0019005]; iron ion binding [GO:0005506]; iron ion homeostasis [GO:0055072]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]","iron ion binding [GO:0005506]","GO:0005506; GO:0006511; GO:0016567; GO:0019005; GO:0031146; GO:0048471; GO:0055072","",""
"22",29,20,28,44,27,26,35,81,44,52,69,90,225,74,91,29,95,95,"g30473",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"23",145,98,217,196,131,104,81,192,136,154,178,164,76,74,151,30,76,68,"g30477",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"24",74,64,100,120,68,63,40,93,107,45,62,56,36,51,81,31,48,60,"g31031",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"25",595,476,1299,820,515,563,484,607,875,555,860,1012,223,247,383,181,354,321,"g31885","P08003",0,"PDIA4_MOUSE","reviewed","Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)","Pdia4 Cai Erp72","Mus musculus (Mouse)",638,"cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; positive regulation of protein folding [GO:1903334]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]","cell [GO:0005623]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]; smooth endoplasmic reticulum [GO:0005790]","cell [GO:0005623]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]; smooth endoplasmic reticulum [GO:0005790]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; positive regulation of protein folding [GO:1903334]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]","peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]","GO:0003756; GO:0005615; GO:0005623; GO:0005783; GO:0005788; GO:0005790; GO:0006457; GO:0009986; GO:0015037; GO:0034663; GO:0034976; GO:0042470; GO:0045454; GO:0061077; GO:1903334","K09582;","mmu:12304;"
"26",98,124,108,124,108,96,95,87,78,97,78,95,42,34,38,11,44,22,"g32116","P41224",1.03e-11,"TEF_RAT","reviewed","Thyrotroph embryonic factor","Tef","Rattus norvegicus (Rat)",301,"positive regulation of transcription by RNA polymerase II [GO:0045944]; rhythmic process [GO:0048511]","nucleus [GO:0005634]","nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rhythmic process [GO:0048511]","DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]","GO:0000977; GO:0000978; GO:0001228; GO:0003690; GO:0005634; GO:0042802; GO:0043565; GO:0044877; GO:0045944; GO:0048511","K09058;","rno:29362;"
"27",2117,2583,3876,3530,2196,1958,701,2550,1769,1802,1805,1766,81,101,74,40,125,169,"g32797","Q7KM13",1.43e-26,"HEY_DROME","reviewed","Hairy/enhancer-of-split related with YRPW motif protein","Hey Hesr-1 CG11194","Drosophila melanogaster (Fruit fly)",425,"anterior/posterior pattern specification [GO:0009952]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate determination [GO:0048664]; Notch signaling pathway [GO:0007219]; regulation of neurogenesis [GO:0050767]","nucleus [GO:0005634]","nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; anterior/posterior pattern specification [GO:0009952]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate determination [GO:0048664]; Notch signaling pathway [GO:0007219]; regulation of neurogenesis [GO:0050767]","DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]","GO:0000122; GO:0000977; GO:0001227; GO:0003677; GO:0005634; GO:0007219; GO:0009952; GO:0030154; GO:0046983; GO:0048664; GO:0050767","K09091;","dme:Dmel_CG11194;"
"28",84,136,130,93,69,70,74,195,348,179,160,163,294,389,442,130,239,199,"g34558","P18293",0,"ANPRA_MOUSE","reviewed","Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A)","Npr1 Npra","Mus musculus (Mouse)",1057,"cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; signal transduction [GO:0007165]","integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]","integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; signal transduction [GO:0007165]","ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]","GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007165; GO:0007166; GO:0007168; GO:0010753; GO:0016021; GO:0016941; GO:0017046; GO:0019901; GO:0019934; GO:0035556; GO:0042417; GO:0042562; GO:0043235; GO:0048662","K12323;","mmu:18160;"
"29",746,664,1313,834,628,810,270,861,1187,425,662,799,332,525,739,191,322,568,"g34594","Q04446",0,"GLGB_HUMAN","reviewed","1,4-alpha-glucan-branching enzyme (EC 2.4.1.18) (Brancher enzyme) (Glycogen-branching enzyme)","GBE1","Homo sapiens (Human)",702,"carbohydrate metabolic process [GO:0005975]; generation of precursor metabolites and energy [GO:0006091]; glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; 1,4-alpha-glucan branching enzyme activity [GO:0003844]; 1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis) [GO:0102752]; cation binding [GO:0043169]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; generation of precursor metabolites and energy [GO:0006091]; glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]","1,4-alpha-glucan branching enzyme activity [GO:0003844]; 1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis) [GO:0102752]; cation binding [GO:0043169]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]","GO:0003844; GO:0004553; GO:0005737; GO:0005829; GO:0005975; GO:0005977; GO:0005978; GO:0006091; GO:0043169; GO:0070062; GO:0102752","K00700;","hsa:2632;"
"30",34,66,191,46,27,162,44,73,140,27,26,136,72,211,160,25,16,489,"g34620","O15439",0,"MRP4_HUMAN","reviewed","Multidrug resistance-associated protein 4 (ATP-binding cassette sub-family C member 4) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B)","ABCC4 MRP4","Homo sapiens (Human)",1325,"cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]","apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]","apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; ion transmembrane transporter activity, phosphorylative mechanism [GO:0015662]; xenobiotic transmembrane transporter activity [GO:0042910]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]","15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562]; ion transmembrane transporter activity, phosphorylative mechanism [GO:0015662]; xenobiotic transmembrane transporter activity [GO:0042910]","GO:0002576; GO:0005524; GO:0005886; GO:0010243; GO:0014070; GO:0015562; GO:0015662; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016404; GO:0016887; GO:0031088; GO:0032310; GO:0042493; GO:0042626; GO:0042910; GO:0048661; GO:0055085; GO:0060271; GO:0098591; GO:0140115","K05673;","hsa:10257;"
"31",432,476,1257,944,452,752,144,945,602,651,591,632,182,191,537,126,128,336,"g34940","A7M9B2",4.47e-07,"TI214_CUSRE","reviewed","Protein TIC 214 (Translocon at the inner envelope membrane of chloroplasts 214) (AtTIC214)","TIC214 ycf1","Cuscuta reflexa (Southern Asian dodder)",1750,"protein transport [GO:0015031]","chloroplast inner membrane [GO:0009706]; integral component of membrane [GO:0016021]","chloroplast inner membrane [GO:0009706]; integral component of membrane [GO:0016021]; protein transport [GO:0015031]","","GO:0009706; GO:0015031; GO:0016021","",""
"32",696,820,1258,886,679,788,445,953,926,711,847,794,436,456,743,243,482,506,"g35960","O43399",1.49e-20,"TPD54_HUMAN","reviewed","Tumor protein D54 (hD54) (Tumor protein D52-like 2)","TPD52L2","Homo sapiens (Human)",206,"regulation of cell population proliferation [GO:0042127]","cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]","cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; catalytic activity [GO:0003824]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; regulation of cell population proliferation [GO:0042127]","catalytic activity [GO:0003824]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]","GO:0003723; GO:0003824; GO:0005737; GO:0042127; GO:0042803; GO:0048471","","hsa:7165;"
"33",55,15,84,32,15,16,72,31,48,59,78,28,422,180,444,155,77,79,"g37889","P9WMV9",4.74e-21,"CHOD_MYCTU","reviewed","Cholesterol oxidase (EC 1.1.3.6) (Cholesterol isomerase) (EC 5.3.3.1)","choD Rv3409c","Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)",578,"cholesterol metabolic process [GO:0008203]; pathogenesis [GO:0009405]; steroid biosynthetic process [GO:0006694]","","cholesterol oxidase activity [GO:0016995]; steroid delta-isomerase activity [GO:0004769]; cholesterol metabolic process [GO:0008203]; pathogenesis [GO:0009405]; steroid biosynthetic process [GO:0006694]","cholesterol oxidase activity [GO:0016995]; steroid delta-isomerase activity [GO:0004769]","GO:0004769; GO:0006694; GO:0008203; GO:0009405; GO:0016995","K03333;","mtu:Rv3409c;mtv:RVBD_3409c;"
"34",47,86,58,74,57,26,139,151,91,153,149,108,415,148,170,53,220,175,"g38587","Q6RI86",1.4e-87,"TRPA1_RAT","reviewed","Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Wasabi receptor)","Trpa1 Anktm1","Rattus norvegicus (Rat)",1125,"calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cell surface receptor signaling pathway [GO:0007166]; cellular response to caffeine [GO:0071313]; cellular response to carbon dioxide [GO:0071244]; cellular response to cold [GO:0070417]; cellular response to heat [GO:0034605]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; positive regulation of anion transport [GO:1903793]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of sensory perception of pain [GO:1904058]; protein homotetramerization [GO:0051289]; regulation of blood circulation [GO:1903522]; regulation of neuronal action potential [GO:0098908]; response to cold [GO:0009409]; response to drug [GO:0042493]; response to hydrogen peroxide [GO:0042542]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to pain [GO:0048265]; sensory perception of pain [GO:0019233]; thermoception [GO:0050955]; urinary bladder smooth muscle contraction [GO:0014832]","apical plasma membrane [GO:0016324]; axon [GO:0030424]; cell [GO:0005623]; integral component of plasma membrane [GO:0005887]; stereocilium bundle [GO:0032421]","apical plasma membrane [GO:0016324]; axon [GO:0030424]; cell [GO:0005623]; integral component of plasma membrane [GO:0005887]; stereocilium bundle [GO:0032421]; calcium channel activity [GO:0005262]; calcium-release channel activity [GO:0015278]; channel activity [GO:0015267]; identical protein binding [GO:0042802]; ion channel activity [GO:0005216]; osmolarity-sensing cation channel activity [GO:1990760]; temperature-gated cation channel activity [GO:0097604]; voltage-gated calcium channel activity [GO:0005245]; calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cell surface receptor signaling pathway [GO:0007166]; cellular response to caffeine [GO:0071313]; cellular response to carbon dioxide [GO:0071244]; cellular response to cold [GO:0070417]; cellular response to heat [GO:0034605]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; positive regulation of anion transport [GO:1903793]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of sensory perception of pain [GO:1904058]; protein homotetramerization [GO:0051289]; regulation of blood circulation [GO:1903522]; regulation of neuronal action potential [GO:0098908]; response to cold [GO:0009409]; response to drug [GO:0042493]; response to hydrogen peroxide [GO:0042542]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to pain [GO:0048265]; sensory perception of pain [GO:0019233]; thermoception [GO:0050955]; urinary bladder smooth muscle contraction [GO:0014832]","calcium channel activity [GO:0005262]; calcium-release channel activity [GO:0015278]; channel activity [GO:0015267]; identical protein binding [GO:0042802]; ion channel activity [GO:0005216]; osmolarity-sensing cation channel activity [GO:1990760]; temperature-gated cation channel activity [GO:0097604]; voltage-gated calcium channel activity [GO:0005245]","GO:0005216; GO:0005245; GO:0005262; GO:0005623; GO:0005887; GO:0006816; GO:0007166; GO:0009409; GO:0010033; GO:0014070; GO:0014832; GO:0015267; GO:0015278; GO:0016324; GO:0019233; GO:0030424; GO:0032421; GO:0034605; GO:0035774; GO:0042493; GO:0042542; GO:0042802; GO:0048265; GO:0050955; GO:0050966; GO:0050968; GO:0051289; GO:0070417; GO:0070588; GO:0071244; GO:0071313; GO:0097553; GO:0097604; GO:0098908; GO:1903522; GO:1903793; GO:1904058; GO:1990760","K04984;","rno:312896;"
"35",3265,1786,4497,4764,3867,3736,870,1647,1630,1367,1766,1516,311,235,609,335,462,376,"g38586","Q16526",1.59e-120,"CRY1_HUMAN","reviewed","Cryptochrome-1","CRY1 PHLL1","Homo sapiens (Human)",586,"blue light signaling pathway [GO:0009785]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA damage induced protein phosphorylation [GO:0006975]; entrainment of circadian clock by photoperiod [GO:0043153]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; lipid storage [GO:0019915]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of glucocorticoid secretion [GO:2000850]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein ubiquitination [GO:0031398]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; regulation of DNA damage checkpoint [GO:2000001]; response to activity [GO:0014823]; response to glucagon [GO:0033762]; response to insulin [GO:0032868]; response to light stimulus [GO:0009416]","mitochondrion [GO:0005739]; nucleus [GO:0005634]","mitochondrion [GO:0005739]; nucleus [GO:0005634]; blue light photoreceptor activity [GO:0009882]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; E-box binding [GO:0070888]; histone deacetylase binding [GO:0042826]; nuclear hormone receptor binding [GO:0035257]; nucleotide binding [GO:0000166]; phosphatase binding [GO:0019902]; protein kinase binding [GO:0019901]; blue light signaling pathway [GO:0009785]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA damage induced protein phosphorylation [GO:0006975]; entrainment of circadian clock by photoperiod [GO:0043153]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; lipid storage [GO:0019915]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of glucocorticoid secretion [GO:2000850]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of protein ubiquitination [GO:0031398]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; regulation of DNA damage checkpoint [GO:2000001]; response to activity [GO:0014823]; response to glucagon [GO:0033762]; response to insulin [GO:0032868]; response to light stimulus [GO:0009416]","blue light photoreceptor activity [GO:0009882]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; E-box binding [GO:0070888]; histone deacetylase binding [GO:0042826]; nuclear hormone receptor binding [GO:0035257]; nucleotide binding [GO:0000166]; phosphatase binding [GO:0019902]; protein kinase binding [GO:0019901]","GO:0000122; GO:0000166; GO:0003677; GO:0003690; GO:0005634; GO:0005739; GO:0006094; GO:0006975; GO:0007623; GO:0009416; GO:0009785; GO:0009882; GO:0014823; GO:0018298; GO:0019901; GO:0019902; GO:0019915; GO:0031397; GO:0031398; GO:0032868; GO:0032922; GO:0033762; GO:0035257; GO:0042593; GO:0042752; GO:0042754; GO:0042826; GO:0043153; GO:0045721; GO:0045744; GO:0045892; GO:0070888; GO:2000001; GO:2000323; GO:2000850","K02295;","hsa:1407;"
"36",34,49,91,75,42,57,23,62,108,30,38,59,13,93,109,7,36,81,"g38718","Q9H0Y0",2.6e-36,"ATG10_HUMAN","reviewed","Ubiquitin-like-conjugating enzyme ATG10 (EC 2.3.2.-) (Autophagy-related protein 10) (APG10-like)","ATG10 APG10L PP12616","Homo sapiens (Human)",220,"autophagy [GO:0006914]; ER overload response [GO:0006983]; macroautophagy [GO:0016236]; positive regulation of protein modification process [GO:0031401]; protein lipidation [GO:0006497]; protein modification by small protein conjugation [GO:0032446]; protein transport [GO:0015031]","cytosol [GO:0005829]; intracellular [GO:0005622]","cytosol [GO:0005829]; intracellular [GO:0005622]; Atg12 transferase activity [GO:0019777]; autophagy [GO:0006914]; ER overload response [GO:0006983]; macroautophagy [GO:0016236]; positive regulation of protein modification process [GO:0031401]; protein lipidation [GO:0006497]; protein modification by small protein conjugation [GO:0032446]; protein transport [GO:0015031]","Atg12 transferase activity [GO:0019777]","GO:0005622; GO:0005829; GO:0006497; GO:0006914; GO:0006983; GO:0015031; GO:0016236; GO:0019777; GO:0031401; GO:0032446","K17888;","hsa:83734;"
"37",564,817,1373,1356,693,633,1048,1819,1820,1575,1710,1478,1446,1220,1556,571,1115,1087,"g39438","Q2EJA0",1.24e-59,"YAP1_RAT","reviewed","Transcriptional coactivator YAP1 (Yes-associated protein 1) (Protein yorkie homolog) (Yes-associated protein YAP65 homolog)","Yap1 Yap Yap65","Rattus norvegicus (Rat)",469,"bud elongation involved in lung branching [GO:0060449]; cardiac muscle tissue regeneration [GO:0061026]; cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to retinoic acid [GO:0071300]; contact inhibition [GO:0060242]; DNA damage induced protein phosphorylation [GO:0006975]; embryonic heart tube morphogenesis [GO:0003143]; heart process [GO:0003015]; hippo signaling [GO:0035329]; keratinocyte differentiation [GO:0030216]; lateral mesoderm development [GO:0048368]; lung epithelial cell differentiation [GO:0060487]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of gene expression [GO:0010629]; negative regulation of stem cell differentiation [GO:2000737]; notochord development [GO:0030903]; paraxial mesoderm development [GO:0048339]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of organ growth [GO:0046622]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; protein-containing complex assembly [GO:0065003]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell population proliferation [GO:0042127]; regulation of gene expression [GO:0010468]; regulation of keratinocyte proliferation [GO:0010837]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]; regulation of neurogenesis [GO:0050767]; regulation of stem cell proliferation [GO:0072091]; response to progesterone [GO:0032570]; somatic stem cell population maintenance [GO:0035019]; tissue homeostasis [GO:0001894]; vasculogenesis [GO:0001570]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TEAD-1-YAP complex [GO:0071148]; TEAD-2-YAP complex [GO:0071149]; transcription factor complex [GO:0005667]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TEAD-1-YAP complex [GO:0071148]; TEAD-2-YAP complex [GO:0071149]; transcription factor complex [GO:0005667]; activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; bud elongation involved in lung branching [GO:0060449]; cardiac muscle tissue regeneration [GO:0061026]; cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to retinoic acid [GO:0071300]; contact inhibition [GO:0060242]; DNA damage induced protein phosphorylation [GO:0006975]; embryonic heart tube morphogenesis [GO:0003143]; heart process [GO:0003015]; hippo signaling [GO:0035329]; keratinocyte differentiation [GO:0030216]; lateral mesoderm development [GO:0048368]; lung epithelial cell differentiation [GO:0060487]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of gene expression [GO:0010629]; negative regulation of stem cell differentiation [GO:2000737]; notochord development [GO:0030903]; paraxial mesoderm development [GO:0048339]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of organ growth [GO:0046622]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; progesterone receptor signaling pathway [GO:0050847]; protein-containing complex assembly [GO:0065003]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell population proliferation [GO:0042127]; regulation of gene expression [GO:0010468]; regulation of keratinocyte proliferation [GO:0010837]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]; regulation of neurogenesis [GO:0050767]; regulation of stem cell proliferation [GO:0072091]; response to progesterone [GO:0032570]; somatic stem cell population maintenance [GO:0035019]; tissue homeostasis [GO:0001894]; vasculogenesis [GO:0001570]","activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]","GO:0000902; GO:0000978; GO:0001570; GO:0001894; GO:0003015; GO:0003143; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006974; GO:0006975; GO:0008022; GO:0008134; GO:0008283; GO:0008284; GO:0010468; GO:0010629; GO:0010837; GO:0016020; GO:0030216; GO:0030857; GO:0030903; GO:0032570; GO:0033148; GO:0033613; GO:0035019; GO:0035329; GO:0042127; GO:0044212; GO:0045893; GO:0045944; GO:0046622; GO:0046982; GO:0048339; GO:0048368; GO:0050679; GO:0050767; GO:0050847; GO:0060045; GO:0060242; GO:0060449; GO:0060487; GO:0060828; GO:0061026; GO:0065003; GO:0070064; GO:0071148; GO:0071149; GO:0071300; GO:0071480; GO:0072091; GO:0072307; GO:0090263; GO:1902459; GO:1904036; GO:2000737; GO:2001237","K16687;","rno:363014;"
"38",6,7,16,14,12,6,0,13,19,0,0,13,15,7,12,0,13,13,"g39753","Q14CM0",2.2e-18,"FRPD4_HUMAN","reviewed","FERM and PDZ domain-containing protein 4 (PDZ domain-containing protein 10) (PSD-95-interacting regulator of spine morphogenesis) (Preso)","FRMPD4 KIAA0316 PDZD10 PDZK10","Homo sapiens (Human)",1322,"positive regulation of synapse structural plasticity [GO:0051835]; postsynaptic actin cytoskeleton organization [GO:0098974]","cell junction [GO:0030054]; cytoskeleton [GO:0005856]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]","cell junction [GO:0030054]; cytoskeleton [GO:0005856]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; positive regulation of synapse structural plasticity [GO:0051835]; postsynaptic actin cytoskeleton organization [GO:0098974]","phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]","GO:0005546; GO:0005856; GO:0014069; GO:0030054; GO:0032991; GO:0043197; GO:0051835; GO:0098974; GO:0098978","","hsa:9758;"
"39",45,83,195,47,29,25,539,197,107,39,509,62,295,107,86,58,167,69,"g40284","Q9HAR2",5.94e-74,"AGRL3_HUMAN","reviewed","Adhesion G protein-coupled receptor L3 (Calcium-independent alpha-latrotoxin receptor 3) (CIRL-3) (Latrophilin-3) (Lectomedin-3)","ADGRL3 KIAA0768 LEC3 LPHN3","Homo sapiens (Human)",1447,"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotion involved in locomotory behavior [GO:0031987]; neuron migration [GO:0001764]; positive regulation of synapse assembly [GO:0051965]; response to cocaine [GO:0042220]; synapse assembly [GO:0007416]","axon [GO:0030424]; cell-cell junction [GO:0005911]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]","axon [GO:0030424]; cell-cell junction [GO:0005911]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotion involved in locomotory behavior [GO:0031987]; neuron migration [GO:0001764]; positive regulation of synapse assembly [GO:0051965]; response to cocaine [GO:0042220]; synapse assembly [GO:0007416]","calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]","GO:0001764; GO:0004930; GO:0005509; GO:0005887; GO:0005911; GO:0007166; GO:0007186; GO:0007189; GO:0007416; GO:0007420; GO:0016021; GO:0030246; GO:0030424; GO:0031987; GO:0042220; GO:0051965; GO:0098742; GO:0098978","K04594;","hsa:23284;"
"40",185,241,312,221,177,178,162,324,290,204,313,230,324,249,453,159,362,366,"g41210","Q8WUB8",2.43e-114,"PHF10_HUMAN","reviewed","PHD finger protein 10 (BRG1-associated factor 45a) (BAF45a) (XAP135)","PHF10 BAF45A","Homo sapiens (Human)",498,"negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]","histone acetyltransferase complex [GO:0000123]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]","histone acetyltransferase complex [GO:0000123]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]","histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; metal ion binding [GO:0046872]","GO:0000123; GO:0000790; GO:0004402; GO:0005634; GO:0005654; GO:0007399; GO:0042393; GO:0045892; GO:0045944; GO:0046872; GO:0071564","K22197;","hsa:55274;"
"41",104,173,179,143,82,89,49,159,178,111,114,121,55,138,177,33,92,189,"g41478","Q5FYB1",0,"ARSI_HUMAN","reviewed","Arylsulfatase I (ASI) (EC 3.1.6.-)","ARSI","Homo sapiens (Human)",569,"","endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]","endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]","arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]","GO:0004065; GO:0005576; GO:0005788; GO:0046872","K12375;","hsa:340075;"
"42",109,100,104,216,114,177,10,61,134,57,51,74,7,45,34,4,34,24,"g41788",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"43",536,428,741,635,381,386,245,617,591,402,449,421,228,174,395,153,315,258,"g47496","Q5S007",1.76e-68,"LRRK2_HUMAN","reviewed","Leucine-rich repeat serine/threonine-protein kinase 2 (EC 2.7.11.1) (EC 3.6.5.-) (Dardarin)","LRRK2 PARK8","Homo sapiens (Human)",2527,"activation of MAPK activity [GO:0000187]; activation of MAPKK activity [GO:0000186]; autophagy [GO:0006914]; calcium-mediated signaling [GO:0019722]; canonical Wnt signaling pathway [GO:0060070]; cellular protein localization [GO:0034613]; cellular response to dopamine [GO:1903351]; cellular response to manganese ion [GO:0071287]; cellular response to oxidative stress [GO:0034599]; cellular response to starvation [GO:0009267]; determination of adult lifespan [GO:0008340]; endocytosis [GO:0006897]; endoplasmic reticulum organization [GO:0007029]; excitatory postsynaptic potential [GO:0060079]; exploration behavior [GO:0035640]; Golgi organization [GO:0007030]; GTP metabolic process [GO:0046039]; intracellular distribution of mitochondria [GO:0048312]; intracellular signal transduction [GO:0035556]; locomotory exploration behavior [GO:0035641]; lysosome organization [GO:0007040]; MAPK cascade [GO:0000165]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of GTPase activity [GO:0034260]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron death [GO:1901215]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein binding [GO:0032091]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein processing [GO:0010955]; negative regulation of protein processing involved in protein targeting to mitochondrion [GO:1903217]; negative regulation of protein targeting to mitochondrion [GO:1903215]; negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation [GO:1903125]; neuromuscular junction development [GO:0007528]; neuron death [GO:0070997]; neuron projection arborization [GO:0140058]; neuron projection morphogenesis [GO:0048812]; olfactory bulb development [GO:0021772]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of programmed cell death [GO:0043068]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein autoubiquitination [GO:1902499]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of tumor necrosis factor secretion [GO:1904469]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to mitochondrion [GO:0070585]; protein phosphorylation [GO:0006468]; reactive oxygen species metabolic process [GO:0072593]; regulation of autophagy [GO:0010506]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of kidney size [GO:0035564]; regulation of locomotion [GO:0040012]; regulation of lysosomal lumen pH [GO:0035751]; regulation of membrane potential [GO:0042391]; regulation of mitochondrial depolarization [GO:0051900]; regulation of mitochondrial fission [GO:0090140]; regulation of neuroblast proliferation [GO:1902692]; regulation of neuron death [GO:1901214]; regulation of neuron maturation [GO:0014041]; regulation of protein kinase A signaling [GO:0010738]; regulation of protein stability [GO:0031647]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle transport [GO:1902803]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; Wnt signalosome assembly [GO:1904887]","amphisome [GO:0044753]; autolysosome [GO:0044754]; axon [GO:0030424]; caveola neck [GO:0099400]; cell [GO:0005623]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic side of mitochondrial outer membrane [GO:0032473]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; inclusion body [GO:0016234]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane raft [GO:0045121]; microvillus [GO:0005902]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; multivesicular body, internal vesicle [GO:0097487]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; Wnt signalosome [GO:1990909]","amphisome [GO:0044753]; autolysosome [GO:0044754]; axon [GO:0030424]; caveola neck [GO:0099400]; cell [GO:0005623]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic side of mitochondrial outer membrane [GO:0032473]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; growth cone [GO:0030426]; inclusion body [GO:0016234]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane raft [GO:0045121]; microvillus [GO:0005902]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; multivesicular body, internal vesicle [GO:0097487]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; Wnt signalosome [GO:1990909]; actin binding [GO:0003779]; ATP binding [GO:0005524]; beta-catenin destruction complex binding [GO:1904713]; clathrin binding [GO:0030276]; co-receptor binding [GO:0039706]; GTP binding [GO:0005525]; GTP-dependent protein kinase activity [GO:0034211]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MAP kinase kinase activity [GO:0004708]; microtubule binding [GO:0008017]; peroxidase inhibitor activity [GO:0036479]; protein homodimerization activity [GO:0042803]; protein kinase A binding [GO:0051018]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; receptor signaling complex adaptor activity [GO:0030159]; Rho GTPase binding [GO:0017048]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; tubulin binding [GO:0015631]; activation of MAPK activity [GO:0000187]; activation of MAPKK activity [GO:0000186]; autophagy [GO:0006914]; calcium-mediated signaling [GO:0019722]; canonical Wnt signaling pathway [GO:0060070]; cellular protein localization [GO:0034613]; cellular response to dopamine [GO:1903351]; cellular response to manganese ion [GO:0071287]; cellular response to oxidative stress [GO:0034599]; cellular response to starvation [GO:0009267]; determination of adult lifespan [GO:0008340]; endocytosis [GO:0006897]; endoplasmic reticulum organization [GO:0007029]; excitatory postsynaptic potential [GO:0060079]; exploration behavior [GO:0035640]; Golgi organization [GO:0007030]; GTP metabolic process [GO:0046039]; intracellular distribution of mitochondria [GO:0048312]; intracellular signal transduction [GO:0035556]; locomotory exploration behavior [GO:0035641]; lysosome organization [GO:0007040]; MAPK cascade [GO:0000165]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of GTPase activity [GO:0034260]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron death [GO:1901215]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein binding [GO:0032091]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein processing [GO:0010955]; negative regulation of protein processing involved in protein targeting to mitochondrion [GO:1903217]; negative regulation of protein targeting to mitochondrion [GO:1903215]; negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation [GO:1903125]; neuromuscular junction development [GO:0007528]; neuron death [GO:0070997]; neuron projection arborization [GO:0140058]; neuron projection morphogenesis [GO:0048812]; olfactory bulb development [GO:0021772]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of programmed cell death [GO:0043068]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein autoubiquitination [GO:1902499]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of tumor necrosis factor secretion [GO:1904469]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to mitochondrion [GO:0070585]; protein phosphorylation [GO:0006468]; reactive oxygen species metabolic process [GO:0072593]; regulation of autophagy [GO:0010506]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of kidney size [GO:0035564]; regulation of locomotion [GO:0040012]; regulation of lysosomal lumen pH [GO:0035751]; regulation of membrane potential [GO:0042391]; regulation of mitochondrial depolarization [GO:0051900]; regulation of mitochondrial fission [GO:0090140]; regulation of neuroblast proliferation [GO:1902692]; regulation of neuron death [GO:1901214]; regulation of neuron maturation [GO:0014041]; regulation of protein kinase A signaling [GO:0010738]; regulation of protein stability [GO:0031647]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle transport [GO:1902803]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; Wnt signalosome assembly [GO:1904887]","actin binding [GO:0003779]; ATP binding [GO:0005524]; beta-catenin destruction complex binding [GO:1904713]; clathrin binding [GO:0030276]; co-receptor binding [GO:0039706]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; GTP-dependent protein kinase activity [GO:0034211]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MAP kinase kinase activity [GO:0004708]; microtubule binding [GO:0008017]; peroxidase inhibitor activity [GO:0036479]; protein homodimerization activity [GO:0042803]; protein kinase A binding [GO:0051018]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; receptor signaling complex adaptor activity [GO:0030159]; Rho GTPase binding [GO:0017048]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; tubulin binding [GO:0015631]","GO:0000139; GO:0000149; GO:0000165; GO:0000186; GO:0000187; GO:0000287; GO:0001933; GO:0001934; GO:0003779; GO:0003924; GO:0004672; GO:0004674; GO:0004708; GO:0005096; GO:0005524; GO:0005525; GO:0005615; GO:0005623; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005759; GO:0005764; GO:0005768; GO:0005783; GO:0005789; GO:0005794; GO:0005798; GO:0005802; GO:0005829; GO:0005886; GO:0005902; GO:0006468; GO:0006606; GO:0006897; GO:0006914; GO:0006979; GO:0007005; GO:0007029; GO:0007030; GO:0007040; GO:0007283; GO:0007528; GO:0008017; GO:0008340; GO:0009267; GO:0010506; GO:0010508; GO:0010738; GO:0010955; GO:0010977; GO:0014041; GO:0015631; GO:0016234; GO:0016242; GO:0016301; GO:0016310; GO:0017048; GO:0017075; GO:0018105; GO:0018107; GO:0019722; GO:0021756; GO:0021772; GO:0022028; GO:0030054; GO:0030159; GO:0030276; GO:0030424; GO:0030425; GO:0030426; GO:0030672; GO:0031398; GO:0031410; GO:0031647; GO:0031966; GO:0032091; GO:0032092; GO:0032436; GO:0032473; GO:0032839; GO:0034211; GO:0034260; GO:0034599; GO:0034613; GO:0035556; GO:0035564; GO:0035640; GO:0035641; GO:0035751; GO:0036479; GO:0039706; GO:0040012; GO:0042391; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0043068; GO:0043195; GO:0043204; GO:0043231; GO:0043406; GO:0044325; GO:0044753; GO:0044754; GO:0045121; GO:0046039; GO:0046777; GO:0048312; GO:0048812; GO:0051018; GO:0051646; GO:0051770; GO:0051900; GO:0051966; GO:0060070; GO:0060079; GO:0060159; GO:0060161; GO:0060628; GO:0060828; GO:0061001; GO:0070062; GO:0070585; GO:0070971; GO:0070973; GO:0070997; GO:0071287; GO:0072593; GO:0090140; GO:0090263; GO:0090394; GO:0097487; GO:0098794; GO:0098978; GO:0099400; GO:0099523; GO:0140058; GO:1900244; GO:1901214; GO:1901215; GO:1901727; GO:1902236; GO:1902499; GO:1902692; GO:1902803; GO:1902823; GO:1902902; GO:1903125; GO:1903206; GO:1903215; GO:1903217; GO:1903351; GO:1903980; GO:1904469; GO:1904713; GO:1904887; GO:1905279; GO:1905289; GO:1990904; GO:1990909; GO:2000172; GO:2000300","K08844;","hsa:120892;"
"44",13,17,66,23,30,13,71,92,152,132,71,98,96,175,119,39,50,97,"g47579","Q9JHB3",7.18e-10,"TIMP4_MOUSE","reviewed","Metalloproteinase inhibitor 4 (Tissue inhibitor of metalloproteinases 4) (TIMP-4)","Timp4","Mus musculus (Mouse)",224,"central nervous system development [GO:0007417]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; Notch signaling pathway [GO:0007219]; ovulation cycle [GO:0042698]; response to cytokine [GO:0034097]; response to drug [GO:0042493]; response to hormone [GO:0009725]; response to lipopolysaccharide [GO:0032496]; response to organic substance [GO:0010033]; response to peptide hormone [GO:0043434]","extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; sarcomere [GO:0030017]","extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; sarcomere [GO:0030017]; metalloendopeptidase inhibitor activity [GO:0008191]; protease binding [GO:0002020]; zinc ion binding [GO:0008270]; central nervous system development [GO:0007417]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; Notch signaling pathway [GO:0007219]; ovulation cycle [GO:0042698]; response to cytokine [GO:0034097]; response to drug [GO:0042493]; response to hormone [GO:0009725]; response to lipopolysaccharide [GO:0032496]; response to organic substance [GO:0010033]; response to peptide hormone [GO:0043434]","metalloendopeptidase inhibitor activity [GO:0008191]; protease binding [GO:0002020]; zinc ion binding [GO:0008270]","GO:0002020; GO:0005615; GO:0007219; GO:0007417; GO:0008191; GO:0008270; GO:0009725; GO:0010033; GO:0010951; GO:0030017; GO:0031012; GO:0032496; GO:0034097; GO:0042493; GO:0042698; GO:0043434; GO:0051045","K22584;","mmu:110595;"
"45",11,10,9,36,15,2,10,6,12,22,23,5,19,3,6,9,22,0,"g47803",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"46",124,126,281,216,122,66,109,372,482,194,276,153,505,426,751,219,520,562,"g48266","Q496Y0",1.81e-104,"LONF3_HUMAN","reviewed","LON peptidase N-terminal domain and RING finger protein 3 (RING finger protein 127)","LONRF3 RNF127","Homo sapiens (Human)",759,"","","metal ion binding [GO:0046872]","metal ion binding [GO:0046872]","GO:0046872","","hsa:79836;"
"47",10,24,10,16,11,34,127,63,129,29,246,20,35,7,17,19,50,30,"g48277",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"48",220,100,87,240,222,53,158,87,91,175,271,64,226,70,50,129,271,47,"g48602","P97819",0,"PLPL9_MOUSE","reviewed","85/88 kDa calcium-independent phospholipase A2 (CaI-PLA2) (EC 3.1.1.4) (Group VI phospholipase A2) (GVI PLA2) (Intracellular membrane-associated calcium-independent phospholipase A2 beta) (iPLA2-beta) (Patatin-like phospholipase domain-containing protein 9) (PNPLA9)","Pla2g6 Pnpla9","Mus musculus (Mouse)",807,"antibacterial humoral response [GO:0019731]; cardiolipin biosynthetic process [GO:0032049]; chemotaxis [GO:0006935]; lipid catabolic process [GO:0016042]; maternal process involved in female pregnancy [GO:0060135]; memory [GO:0007613]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; regulation of store-operated calcium channel activity [GO:1901339]; response to endoplasmic reticulum stress [GO:0034976]; urinary bladder smooth muscle contraction [GO:0014832]","cell [GO:0005623]; centriolar satellite [GO:0034451]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; mitochondrion [GO:0005739]","cell [GO:0005623]; centriolar satellite [GO:0034451]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; mitochondrion [GO:0005739]; ATP-dependent protein binding [GO:0043008]; calcium-independent phospholipase A2 activity [GO:0047499]; calmodulin binding [GO:0005516]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; protein kinase binding [GO:0019901]; serine hydrolase activity [GO:0017171]; antibacterial humoral response [GO:0019731]; cardiolipin biosynthetic process [GO:0032049]; chemotaxis [GO:0006935]; lipid catabolic process [GO:0016042]; maternal process involved in female pregnancy [GO:0060135]; memory [GO:0007613]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; regulation of store-operated calcium channel activity [GO:1901339]; response to endoplasmic reticulum stress [GO:0034976]; urinary bladder smooth muscle contraction [GO:0014832]","ATP-dependent protein binding [GO:0043008]; calcium-independent phospholipase A2 activity [GO:0047499]; calmodulin binding [GO:0005516]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; protein kinase binding [GO:0019901]; serine hydrolase activity [GO:0017171]","GO:0001934; GO:0005516; GO:0005615; GO:0005623; GO:0005739; GO:0005829; GO:0006935; GO:0007204; GO:0007613; GO:0014832; GO:0016020; GO:0016042; GO:0017171; GO:0019731; GO:0019901; GO:0032049; GO:0034451; GO:0034976; GO:0035774; GO:0043008; GO:0045921; GO:0047499; GO:0051967; GO:0060135; GO:0090037; GO:0090200; GO:0090238; GO:0097755; GO:0102567; GO:0102568; GO:1901339; GO:2000304","K16343;","mmu:53357;"
"49",855,943,2243,1732,899,1504,248,1741,1058,1145,1062,1158,283,380,978,251,222,583,"g49518",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"50",507,509,777,801,498,454,419,588,763,541,698,626,922,809,1011,611,1020,994,"g50751","E7F9T0",2.4e-163,"MICA1_DANRE","reviewed","[F-actin]-monooxygenase mical1 (EC 1.14.13.225) (Molecule interacting with CasL protein 1) (MICAL-1)","mical1","Danio rerio (Zebrafish) (Brachydanio rerio)",1214,"actin cytoskeleton organization [GO:0030036]; actin filament depolymerization [GO:0030042]; oxidation-reduction process [GO:0055114]; sulfur oxidation [GO:0019417]","cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; microtubule organizing center [GO:0005815]","cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; microtubule organizing center [GO:0005815]; actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; actin cytoskeleton organization [GO:0030036]; actin filament depolymerization [GO:0030042]; oxidation-reduction process [GO:0055114]; sulfur oxidation [GO:0019417]","actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]","GO:0003779; GO:0005737; GO:0005815; GO:0016709; GO:0019417; GO:0030036; GO:0030042; GO:0031941; GO:0046872; GO:0055114; GO:0071949","K19947;","dre:568573;"
"51",167,272,580,503,286,243,271,381,795,756,546,374,746,727,1072,423,798,710,"g53963","Q8N5H7",1.2e-10,"SH2D3_HUMAN","reviewed","SH2 domain-containing protein 3C (Cas/HEF1-associated signal transducer) (Chat-H) (Novel SH2-containing protein 3) (SH2 domain-containing Eph receptor-binding protein 1) (SHEP1)","SH2D3C NSP3 UNQ272/PRO309/PRO34088","Homo sapiens (Human)",860,"JNK cascade [GO:0007254]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; small GTPase mediated signal transduction [GO:0007264]","cytoplasm [GO:0005737]; membrane [GO:0016020]","cytoplasm [GO:0005737]; membrane [GO:0016020]; guanyl-nucleotide exchange factor activity [GO:0005085]; SH3/SH2 adaptor activity [GO:0005070]; JNK cascade [GO:0007254]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; small GTPase mediated signal transduction [GO:0007264]","guanyl-nucleotide exchange factor activity [GO:0005085]; SH3/SH2 adaptor activity [GO:0005070]","GO:0005070; GO:0005085; GO:0005737; GO:0007254; GO:0007264; GO:0016020; GO:0033138","K23690;","hsa:10044;"
"52",173,115,122,181,311,77,174,191,113,211,316,110,269,125,130,130,446,105,"g57309","Q66PG1",0,"LARG2_DANRE","reviewed","LARGE xylosyl- and glucuronyltransferase 2 (EC 2.4.-.-) (Glycosyltransferase-like 1B) [Includes: Xylosyltransferase LARGE2 (EC 2.4.2.-); Beta-1,3-glucuronyltransferase LARGE2 (EC 2.4.1.-)]","large2 gyltl1b si:ch211-206g24.1 si:ch211-282n12.1","Danio rerio (Zebrafish) (Brachydanio rerio)",750,"protein glycosylation [GO:0006486]; protein O-linked mannosylation [GO:0035269]","Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]","Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; transferase activity, transferring glycosyl groups [GO:0016757]; xylosyltransferase activity [GO:0042285]; protein glycosylation [GO:0006486]; protein O-linked mannosylation [GO:0035269]","glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; transferase activity, transferring glycosyl groups [GO:0016757]; xylosyltransferase activity [GO:0042285]","GO:0000139; GO:0005794; GO:0006486; GO:0015020; GO:0016021; GO:0016757; GO:0035269; GO:0042285; GO:0046872","K09668;","dre:446214;"
"53",512,589,1066,1070,610,1321,189,684,587,480,576,937,154,225,254,99,152,259,"g57313","Q6YGZ4",8.42e-66,"CLOCK_TYTAL","reviewed","Circadian locomoter output cycles protein kaput","CLOCK","Tyto alba (Barn owl)",851,"cellular response to DNA damage stimulus [GO:0006974]; protein acetylation [GO:0006473]; response to redox state [GO:0051775]; rhythmic process [GO:0048511]","cytosol [GO:0005829]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]","cytosol [GO:0005829]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein dimerization activity [GO:0046983]; cellular response to DNA damage stimulus [GO:0006974]; protein acetylation [GO:0006473]; response to redox state [GO:0051775]; rhythmic process [GO:0048511]","DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein dimerization activity [GO:0046983]","GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0005829; GO:0006473; GO:0006974; GO:0046983; GO:0048511; GO:0051775","",""
"54",186,141,298,298,215,242,46,163,123,113,115,121,22,23,32,21,14,39,"g57314","Q99743",2.3e-53,"NPAS2_HUMAN","reviewed","Neuronal PAS domain-containing protein 2 (Neuronal PAS2) (Basic-helix-loop-helix-PAS protein MOP4) (Class E basic helix-loop-helix protein 9) (bHLHe9) (Member of PAS protein 4) (PAS domain-containing protein 4)","NPAS2 BHLHE9 MOP4 PASD4","Homo sapiens (Human)",824,"cellular response to DNA damage stimulus [GO:0006974]; central nervous system development [GO:0007417]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; negative regulation of cell death [GO:0060548]; positive regulation of behavioral fear response [GO:2000987]; positive regulation of DNA repair [GO:0045739]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of lipid metabolic process [GO:0019216]; regulation of response to DNA damage stimulus [GO:2001020]; response to drug [GO:0042493]; response to redox state [GO:0051775]","cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]","cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; Hsp90 protein binding [GO:0051879]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cellular response to DNA damage stimulus [GO:0006974]; central nervous system development [GO:0007417]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; negative regulation of cell death [GO:0060548]; positive regulation of behavioral fear response [GO:2000987]; positive regulation of DNA repair [GO:0045739]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of lipid metabolic process [GO:0019216]; regulation of response to DNA damage stimulus [GO:2001020]; response to drug [GO:0042493]; response to redox state [GO:0051775]","DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; Hsp90 protein binding [GO:0051879]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]","GO:0000790; GO:0000978; GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006974; GO:0007417; GO:0007623; GO:0019216; GO:0032922; GO:0042493; GO:0045739; GO:0045893; GO:0045944; GO:0046872; GO:0046983; GO:0051775; GO:0051879; GO:0060548; GO:2000987; GO:2001020","K09026;","hsa:4862;"
"55",25,52,90,35,25,15,54,167,143,31,151,126,288,163,130,21,106,103,"g58055","Q9UBH6",3.96e-105,"XPR1_HUMAN","reviewed","Xenotropic and polytropic retrovirus receptor 1 (Protein SYG1 homolog) (Xenotropic and polytropic murine leukemia virus receptor X3) (X-receptor)","XPR1 SYG1 XR","Homo sapiens (Human)",696,"cellular phosphate ion homeostasis [GO:0030643]; cellular response to phosphate starvation [GO:0016036]; G protein-coupled receptor signaling pathway [GO:0007186]; phosphate ion transmembrane transport [GO:0035435]; phosphate ion transport [GO:0006817]; response to virus [GO:0009615]","cell [GO:0005623]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]","cell [GO:0005623]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]; efflux transmembrane transporter activity [GO:0015562]; G protein-coupled receptor activity [GO:0004930]; inositol hexakisphosphate binding [GO:0000822]; phosphate ion transmembrane transporter activity [GO:0015114]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to phosphate starvation [GO:0016036]; G protein-coupled receptor signaling pathway [GO:0007186]; phosphate ion transmembrane transport [GO:0035435]; phosphate ion transport [GO:0006817]; response to virus [GO:0009615]","efflux transmembrane transporter activity [GO:0015562]; G protein-coupled receptor activity [GO:0004930]; inositol hexakisphosphate binding [GO:0000822]; phosphate ion transmembrane transporter activity [GO:0015114]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]","GO:0000822; GO:0001618; GO:0004888; GO:0004930; GO:0005623; GO:0005737; GO:0005794; GO:0005886; GO:0006817; GO:0007186; GO:0009615; GO:0015114; GO:0015562; GO:0016021; GO:0016036; GO:0030643; GO:0031226; GO:0035435; GO:0038023","","hsa:9213;"
"56",808,1114,1870,1062,605,764,582,1996,2073,925,1151,1143,831,1337,2038,473,975,1455,"g58395","C3YWU0",0,"FUCO_BRAFL","reviewed","Alpha-L-fucosidase (EC 3.2.1.51) (Alpha-L-fucoside fucohydrolase)","BRAFLDRAFT_56888","Branchiostoma floridae (Florida lancelet) (Amphioxus)",449,"fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139]","extracellular region [GO:0005576]; lysosome [GO:0005764]","extracellular region [GO:0005576]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139]","alpha-L-fucosidase activity [GO:0004560]","GO:0004560; GO:0005576; GO:0005764; GO:0006004; GO:0016139","K01206;","bfo:BRAFLDRAFT_56888;"
"57",88,85,180,105,38,87,64,118,145,81,145,107,76,40,71,76,107,38,"g60401","P62315",6.24e-56,"SMD1_MOUSE","reviewed","Small nuclear ribonucleoprotein Sm D1 (Sm-D1) (Sm-D autoantigen) (snRNP core protein D1)","Snrpd1","Mus musculus (Mouse)",119,"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]","catalytic step 2 spliceosome [GO:0071013]; commitment complex [GO:0000243]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; SMN-Sm protein complex [GO:0034719]; spliceosomal tri-snRNP complex [GO:0097526]; U12-type spliceosomal complex [GO:0005689]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4 snRNP [GO:0005687]; U5 snRNP [GO:0005682]","catalytic step 2 spliceosome [GO:0071013]; commitment complex [GO:0000243]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; SMN-Sm protein complex [GO:0034719]; spliceosomal tri-snRNP complex [GO:0097526]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; RNA binding [GO:0003723]; U1 snRNP binding [GO:1990446]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]","RNA binding [GO:0003723]; U1 snRNP binding [GO:1990446]","GO:0000243; GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005682; GO:0005685; GO:0005686; GO:0005687; GO:0005689; GO:0005737; GO:0005829; GO:0034709; GO:0034715; GO:0034719; GO:0046540; GO:0071005; GO:0071007; GO:0071011; GO:0071013; GO:0097526; GO:1990446","K11087;","mmu:20641;"
"58",117,165,216,168,147,80,131,273,260,228,228,168,222,235,301,179,306,257,"g63260","O43581",1.74e-24,"SYT7_HUMAN","reviewed","Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII)","SYT7 PCANAP7","Homo sapiens (Human)",403,"calcium-dependent activation of synaptic vesicle fusion [GO:0099502]; calcium-ion regulated exocytosis [GO:0017156]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium ion regulated lysosome exocytosis [GO:1990927]; cellular response to calcium ion [GO:0071277]; phagocytosis [GO:0006909]; phagosome-lysosome fusion [GO:0090385]; plasma membrane repair [GO:0001778]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of bone remodeling [GO:0046850]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of glucagon secretion [GO:0070092]; regulation of insulin secretion [GO:0050796]; regulation of phagocytosis [GO:0050764]; regulation of synaptic vesicle endocytosis [GO:1900242]; short-term synaptic potentiation [GO:1990926]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated cholesterol transport [GO:0090119]; vesicle-mediated transport [GO:0016192]","axon terminus [GO:0043679]; cell junction [GO:0030054]; cytosol [GO:0005829]; dendrite [GO:0030425]; dense core granule [GO:0031045]; early phagosome [GO:0032009]; exocytic vesicle [GO:0070382]; extracellular exosome [GO:0070062]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of presynaptic membrane [GO:0099056]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]","axon terminus [GO:0043679]; cell junction [GO:0030054]; cytosol [GO:0005829]; dendrite [GO:0030425]; dense core granule [GO:0031045]; early phagosome [GO:0032009]; exocytic vesicle [GO:0070382]; extracellular exosome [GO:0070062]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of presynaptic membrane [GO:0099056]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calmodulin binding [GO:0005516]; clathrin binding [GO:0030276]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium ion regulated lysosome exocytosis [GO:1990927]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-dependent activation of synaptic vesicle fusion [GO:0099502]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; phagocytosis [GO:0006909]; phagosome-lysosome fusion [GO:0090385]; plasma membrane repair [GO:0001778]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of bone remodeling [GO:0046850]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of glucagon secretion [GO:0070092]; regulation of insulin secretion [GO:0050796]; regulation of phagocytosis [GO:0050764]; regulation of synaptic vesicle endocytosis [GO:1900242]; short-term synaptic potentiation [GO:1990926]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated cholesterol transport [GO:0090119]; vesicle-mediated transport [GO:0016192]","calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; clathrin binding [GO:0030276]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]","GO:0000149; GO:0001778; GO:0001786; GO:0005509; GO:0005516; GO:0005544; GO:0005546; GO:0005764; GO:0005765; GO:0005777; GO:0005778; GO:0005829; GO:0005886; GO:0006909; GO:0008021; GO:0014059; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030054; GO:0030276; GO:0030425; GO:0030670; GO:0030672; GO:0031045; GO:0032009; GO:0036465; GO:0043025; GO:0043679; GO:0045956; GO:0046850; GO:0048791; GO:0050764; GO:0050796; GO:0070062; GO:0070092; GO:0070382; GO:0071277; GO:0090119; GO:0090385; GO:0098686; GO:0098978; GO:0098982; GO:0099056; GO:0099502; GO:1900242; GO:1990926; GO:1990927","K19907;","hsa:9066;"
"59",5,6,24,0,0,9,44,44,34,75,72,29,221,29,52,25,27,91,"g64233","Q6NUT3",1.2e-21,"MFS12_HUMAN","reviewed","Major facilitator superfamily domain-containing protein 12","MFSD12 C19orf28","Homo sapiens (Human)",480,"carbohydrate transport [GO:0008643]; negative regulation of melanin biosynthetic process [GO:0048022]; organic substance transport [GO:0071702]","integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]","integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; symporter activity [GO:0015293]; carbohydrate transport [GO:0008643]; negative regulation of melanin biosynthetic process [GO:0048022]; organic substance transport [GO:0071702]","symporter activity [GO:0015293]","GO:0005765; GO:0005770; GO:0005887; GO:0008643; GO:0015293; GO:0048022; GO:0071702","","hsa:126321;"
"60",5,19,18,11,0,0,54,21,46,41,106,47,197,95,94,14,22,71,"g64424","Q7ZWG6",8.02e-58,"PCFT_DANRE","reviewed","Proton-coupled folate transporter (Heme carrier protein 1) (PCFT/HCP1) (Solute carrier family 46 member 1)","slc46a1 hcp1 pcft zgc:56400","Danio rerio (Zebrafish) (Brachydanio rerio)",481,"transmembrane transport [GO:0055085]","integral component of membrane [GO:0016021]","integral component of membrane [GO:0016021]; folic acid binding [GO:0005542]; transmembrane transport [GO:0055085]","folic acid binding [GO:0005542]","GO:0005542; GO:0016021; GO:0055085","K14613;","dre:393255;"
"61",361,673,900,947,379,304,736,1328,1281,842,1102,812,1776,1154,1485,514,1124,1131,"g64474","P48999",1.1e-107,"LOX5_MOUSE","reviewed","Arachidonate 5-lipoxygenase (5-LO) (5-lipoxygenase) (EC 1.13.11.34)","Alox5","Mus musculus (Mouse)",674,"acute inflammatory response [GO:0002526]; dendritic cell migration [GO:0036336]; glucose homeostasis [GO:0042593]; humoral immune response [GO:0006959]; inflammatory response [GO:0006954]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; leukocyte migration involved in inflammatory response [GO:0002523]; leukotriene A4 biosynthetic process [GO:1901753]; leukotriene biosynthetic process [GO:0019370]; leukotriene metabolic process [GO:0006691]; leukotriene production involved in inflammatory response [GO:0002540]; lipoxin biosynthetic process [GO:2001301]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular wound healing [GO:0061044]; negative regulation of wound healing [GO:0061045]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cytochrome-c oxidase activity [GO:1904960]; positive regulation of leukocyte adhesion to arterial endothelial cell [GO:1904999]; positive regulation of vasoconstriction [GO:0045907]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of fat cell differentiation [GO:0045598]; regulation of inflammatory response [GO:0050727]; regulation of inflammatory response to wounding [GO:0106014]; regulation of insulin secretion [GO:0050796]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; sensory perception of pain [GO:0019233]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; nuclear envelope [GO:0005635]; nuclear envelope lumen [GO:0005641]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; sarcolemma [GO:0042383]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; nuclear envelope [GO:0005635]; nuclear envelope lumen [GO:0005641]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; sarcolemma [GO:0042383]; arachidonate 5-lipoxygenase activity [GO:0004051]; iron ion binding [GO:0005506]; acute inflammatory response [GO:0002526]; dendritic cell migration [GO:0036336]; glucose homeostasis [GO:0042593]; humoral immune response [GO:0006959]; inflammatory response [GO:0006954]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; leukocyte migration involved in inflammatory response [GO:0002523]; leukotriene A4 biosynthetic process [GO:1901753]; leukotriene biosynthetic process [GO:0019370]; leukotriene metabolic process [GO:0006691]; leukotriene production involved in inflammatory response [GO:0002540]; lipoxin biosynthetic process [GO:2001301]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular wound healing [GO:0061044]; negative regulation of wound healing [GO:0061045]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cytochrome-c oxidase activity [GO:1904960]; positive regulation of leukocyte adhesion to arterial endothelial cell [GO:1904999]; positive regulation of vasoconstriction [GO:0045907]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of fat cell differentiation [GO:0045598]; regulation of inflammatory response [GO:0050727]; regulation of inflammatory response to wounding [GO:0106014]; regulation of insulin secretion [GO:0050796]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; sensory perception of pain [GO:0019233]","arachidonate 5-lipoxygenase activity [GO:0004051]; iron ion binding [GO:0005506]","GO:0001937; GO:0002232; GO:0002523; GO:0002526; GO:0002540; GO:0004051; GO:0005506; GO:0005634; GO:0005635; GO:0005641; GO:0005654; GO:0005737; GO:0005829; GO:0006691; GO:0006954; GO:0006959; GO:0016363; GO:0016525; GO:0019233; GO:0019370; GO:0030425; GO:0030501; GO:0031965; GO:0036336; GO:0042383; GO:0042593; GO:0045598; GO:0045907; GO:0048471; GO:0050727; GO:0050728; GO:0050796; GO:0061044; GO:0061045; GO:0106014; GO:1900015; GO:1900407; GO:1901753; GO:1903426; GO:1903573; GO:1903671; GO:1904960; GO:1904999; GO:2001301","K00461;","mmu:11689;"
"62",33205,35212,48336,34463,26593,29184,21994,38004,35858,25586,33120,36258,17179,17149,26531,10883,24400,17839,"g64793","P69005",0,"ACTD_STRPU","reviewed","Actin, cytoskeletal 2B (Actin, cytoskeletal IIB)","CYIIB SPEC3","Strongylocentrotus purpuratus (Purple sea urchin)",376,"","actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]","actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]","ATP binding [GO:0005524]","GO:0005524; GO:0005737; GO:0015629","K05692;","spu:115917875;spu:373190;spu:373192;"
"63",16,41,49,34,43,12,4,37,75,28,20,19,0,31,45,0,0,6,"g67292",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"64",253,317,548,500,343,368,81,292,203,221,182,228,6,0,8,0,13,15,"g67932","Q7KM13",5.63e-15,"HEY_DROME","reviewed","Hairy/enhancer-of-split related with YRPW motif protein","Hey Hesr-1 CG11194","Drosophila melanogaster (Fruit fly)",425,"anterior/posterior pattern specification [GO:0009952]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate determination [GO:0048664]; Notch signaling pathway [GO:0007219]; regulation of neurogenesis [GO:0050767]","nucleus [GO:0005634]","nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; anterior/posterior pattern specification [GO:0009952]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate determination [GO:0048664]; Notch signaling pathway [GO:0007219]; regulation of neurogenesis [GO:0050767]","DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]","GO:0000122; GO:0000977; GO:0001227; GO:0003677; GO:0005634; GO:0007219; GO:0009952; GO:0030154; GO:0046983; GO:0048664; GO:0050767","K09091;","dme:Dmel_CG11194;"
"65",30,63,103,63,43,53,12,82,92,36,42,54,26,57,121,24,26,85,"g70488","A0FI79",1.78e-121,"INP5E_PANTR","reviewed","Phosphatidylinositol polyphosphate 5-phosphatase type IV (72 kDa inositol polyphosphate 5-phosphatase) (Inositol polyphosphate-5-phosphatase E) (Phosphatidylinositol 4,5-bisphosphate 5-phosphatase) (EC 3.1.3.36) (Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase) (EC 3.1.3.86)","INPP5E","Pan troglodytes (Chimpanzee)",644,"phosphatidylinositol dephosphorylation [GO:0046856]","axoneme [GO:0005930]; Golgi cisterna membrane [GO:0032580]; plasma membrane [GO:0005886]; ruffle [GO:0001726]","axoneme [GO:0005930]; Golgi cisterna membrane [GO:0032580]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; phosphatidylinositol dephosphorylation [GO:0046856]","inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]","GO:0001726; GO:0004439; GO:0004445; GO:0005886; GO:0005930; GO:0032580; GO:0046856","K20278;","ptr:748603;"
"66",9,61,74,7,0,64,18,95,84,26,27,73,9,72,71,9,8,63,"g89","P53349",8.49e-21,"M3K1_MOUSE","reviewed","Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1)","Map3k1 Mekk Mekk1","Mus musculus (Mouse)",1493,"activation of JUN kinase activity [GO:0007257]; activation of protein kinase activity [GO:0032147]; apoptotic mitochondrial changes [GO:0008637]; camera-type eye development [GO:0043010]; epithelial cell morphogenesis [GO:0003382]; eyelid development in camera-type eye [GO:0061029]; JNK cascade [GO:0007254]; morphogenesis of an epithelial sheet [GO:0002011]; positive regulation of actin filament polymerization [GO:0030838]; regulation of cell migration [GO:0030334]; regulation of mitotic cell cycle [GO:0007346]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]; transforming growth factor beta receptor signaling pathway [GO:0007179]; wound healing [GO:0042060]","cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; membrane [GO:0016020]","cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; membrane [GO:0016020]; ATP binding [GO:0005524]; cytoskeletal protein binding [GO:0008092]; JUN kinase binding [GO:0008432]; JUN kinase kinase kinase activity [GO:0004706]; MAP kinase kinase kinase activity [GO:0004709]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; sphingolipid binding [GO:0046625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; activation of JUN kinase activity [GO:0007257]; activation of protein kinase activity [GO:0032147]; apoptotic mitochondrial changes [GO:0008637]; camera-type eye development [GO:0043010]; epithelial cell morphogenesis [GO:0003382]; eyelid development in camera-type eye [GO:0061029]; JNK cascade [GO:0007254]; morphogenesis of an epithelial sheet [GO:0002011]; positive regulation of actin filament polymerization [GO:0030838]; regulation of cell migration [GO:0030334]; regulation of mitotic cell cycle [GO:0007346]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]; transforming growth factor beta receptor signaling pathway [GO:0007179]; wound healing [GO:0042060]","ATP binding [GO:0005524]; cytoskeletal protein binding [GO:0008092]; JUN kinase binding [GO:0008432]; JUN kinase kinase kinase activity [GO:0004706]; MAP kinase kinase kinase activity [GO:0004709]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein-containing complex binding [GO:0044877]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; sphingolipid binding [GO:0046625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]","GO:0002011; GO:0003382; GO:0004672; GO:0004674; GO:0004706; GO:0004709; GO:0004842; GO:0005524; GO:0005737; GO:0005829; GO:0007179; GO:0007254; GO:0007257; GO:0007346; GO:0008092; GO:0008270; GO:0008432; GO:0008637; GO:0016020; GO:0019901; GO:0023014; GO:0030054; GO:0030334; GO:0030838; GO:0031098; GO:0031434; GO:0031941; GO:0032147; GO:0042060; GO:0043010; GO:0044877; GO:0046625; GO:0051019; GO:0061029","",""
"67",12,47,162,20,11,63,21,66,156,5,16,73,9,22,96,2,6,87,"g1148",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"68",122,173,131,243,99,32,232,264,290,1237,250,294,1532,1200,1472,645,614,971,"g2645","P47863",1.03e-62,"AQP4_RAT","reviewed","Aquaporin-4 (AQP-4) (Mercurial-insensitive water channel) (MIWC) (WCH4)","Aqp4","Rattus norvegicus (Rat)",323,"carbon dioxide transport [GO:0015670]; cell-cell adhesion [GO:0098609]; cellular response to estradiol stimulus [GO:0071392]; cellular response to glucose stimulus [GO:0071333]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cellular water homeostasis [GO:0009992]; cerebrospinal fluid circulation [GO:0090660]; female pregnancy [GO:0007565]; hyperosmotic salinity response [GO:0042538]; multicellular organismal water homeostasis [GO:0050891]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; protein homotetramerization [GO:0051289]; regulation of vascular endothelial growth factor production [GO:0010574]; renal water absorption [GO:0070295]; response to glucocorticoid [GO:0051384]; response to radiation [GO:0009314]; sensory perception of sound [GO:0007605]; water homeostasis [GO:0030104]; water transport [GO:0006833]","astrocyte end-foot [GO:0097450]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cell-cell junction [GO:0005911]; cell projection membrane [GO:0031253]; cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]","astrocyte end-foot [GO:0097450]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cell projection membrane [GO:0031253]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; identical protein binding [GO:0042802]; porin activity [GO:0015288]; water channel activity [GO:0015250]; carbon dioxide transport [GO:0015670]; cell-cell adhesion [GO:0098609]; cellular response to estradiol stimulus [GO:0071392]; cellular response to glucose stimulus [GO:0071333]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cellular water homeostasis [GO:0009992]; cerebrospinal fluid circulation [GO:0090660]; female pregnancy [GO:0007565]; hyperosmotic salinity response [GO:0042538]; multicellular organismal water homeostasis [GO:0050891]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; protein homotetramerization [GO:0051289]; regulation of vascular endothelial growth factor production [GO:0010574]; renal water absorption [GO:0070295]; response to glucocorticoid [GO:0051384]; response to radiation [GO:0009314]; sensory perception of sound [GO:0007605]; water homeostasis [GO:0030104]; water transport [GO:0006833]","identical protein binding [GO:0042802]; porin activity [GO:0015288]; water channel activity [GO:0015250]","GO:0005576; GO:0005623; GO:0005737; GO:0005886; GO:0005887; GO:0005911; GO:0006833; GO:0007565; GO:0007605; GO:0009314; GO:0009897; GO:0009925; GO:0009992; GO:0010008; GO:0010574; GO:0015250; GO:0015288; GO:0015670; GO:0016020; GO:0016021; GO:0016323; GO:0030104; GO:0030315; GO:0031253; GO:0032691; GO:0032715; GO:0032991; GO:0042383; GO:0042538; GO:0042802; GO:0050891; GO:0051289; GO:0051384; GO:0060354; GO:0070295; GO:0071333; GO:0071346; GO:0071347; GO:0071354; GO:0071392; GO:0090660; GO:0097450; GO:0098609","K09866;","rno:25293;"
"69",364,453,650,416,356,344,226,737,648,267,417,529,544,592,745,304,584,566,"g3494","P48507",3.16e-66,"GSH0_HUMAN","reviewed","Glutamate--cysteine ligase regulatory subunit (GCS light chain) (Gamma-ECS regulatory subunit) (Gamma-glutamylcysteine synthetase regulatory subunit) (Glutamate--cysteine ligase modifier subunit)","GCLM GLCLR","Homo sapiens (Human)",274,"aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; hepatic stellate cell activation [GO:0035733]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of glutamate-cysteine ligase activity [GO:0035229]; regulation of blood vessel diameter [GO:0097746]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to human chorionic gonadotropin [GO:0044752]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]","cell [GO:0005623]; cytosol [GO:0005829]; glutamate-cysteine ligase complex [GO:0017109]","cell [GO:0005623]; cytosol [GO:0005829]; glutamate-cysteine ligase complex [GO:0017109]; enzyme regulator activity [GO:0030234]; glutamate-cysteine ligase activity [GO:0004357]; glutamate-cysteine ligase catalytic subunit binding [GO:0035226]; protein-containing complex binding [GO:0044877]; aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; hepatic stellate cell activation [GO:0035733]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of glutamate-cysteine ligase activity [GO:0035229]; regulation of blood vessel diameter [GO:0097746]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to human chorionic gonadotropin [GO:0044752]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]","enzyme regulator activity [GO:0030234]; glutamate-cysteine ligase activity [GO:0004357]; glutamate-cysteine ligase catalytic subunit binding [GO:0035226]; protein-containing complex binding [GO:0044877]","GO:0004357; GO:0005623; GO:0005829; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0014823; GO:0017109; GO:0030234; GO:0035226; GO:0035229; GO:0035729; GO:0035733; GO:0042493; GO:0043524; GO:0044344; GO:0044752; GO:0044877; GO:0051409; GO:0051900; GO:0071333; GO:0071372; GO:0097069; GO:0097746; GO:1990830; GO:2001237","K11205;","hsa:2730;"
"70",288,42,41,489,238,31,292,26,29,429,392,31,294,13,17,164,460,43,"g4222","P48994",2.17e-12,"TRPL_DROME","reviewed","Transient-receptor-potential-like protein","trpl CG18345","Drosophila melanogaster (Fruit fly)",1124,"body fluid secretion [GO:0007589]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cation transport [GO:0006812]; cellular response to anoxia [GO:0071454]; detection of light stimulus involved in visual perception [GO:0050908]; ion transport [GO:0006811]; manganese ion transport [GO:0006828]; phototransduction, visible light [GO:0007603]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to light stimulus [GO:0009416]; sensory perception of sound [GO:0007605]","cation channel complex [GO:0034703]; cell [GO:0005623]; dendrite [GO:0030425]; inaD signaling complex [GO:0016027]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; rhabdomere microvillus membrane [GO:0035997]","cation channel complex [GO:0034703]; cell [GO:0005623]; dendrite [GO:0030425]; inaD signaling complex [GO:0016027]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; rhabdomere microvillus membrane [GO:0035997]; calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; cation channel activity [GO:0005261]; identical protein binding [GO:0042802]; inositol 1,4,5 trisphosphate binding [GO:0070679]; ion transmembrane transporter activity [GO:0015075]; light-activated ion channel activity [GO:0010461]; protein heterodimerization activity [GO:0046982]; store-operated calcium channel activity [GO:0015279]; body fluid secretion [GO:0007589]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cation transport [GO:0006812]; cellular response to anoxia [GO:0071454]; detection of light stimulus involved in visual perception [GO:0050908]; ion transport [GO:0006811]; manganese ion transport [GO:0006828]; phototransduction, visible light [GO:0007603]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to light stimulus [GO:0009416]; sensory perception of sound [GO:0007605]","calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; cation channel activity [GO:0005261]; identical protein binding [GO:0042802]; inositol 1,4,5 trisphosphate binding [GO:0070679]; ion transmembrane transporter activity [GO:0015075]; light-activated ion channel activity [GO:0010461]; protein heterodimerization activity [GO:0046982]; store-operated calcium channel activity [GO:0015279]","GO:0005261; GO:0005262; GO:0005516; GO:0005623; GO:0005886; GO:0005887; GO:0006811; GO:0006812; GO:0006816; GO:0006828; GO:0007589; GO:0007603; GO:0007605; GO:0009416; GO:0010461; GO:0015075; GO:0015279; GO:0016021; GO:0016027; GO:0016028; GO:0019722; GO:0030425; GO:0034703; GO:0035997; GO:0042802; GO:0046982; GO:0050908; GO:0051480; GO:0070588; GO:0070679; GO:0071454","K13803;","dme:Dmel_CG18345;"
"71",0,39,42,6,5,13,145,16,40,5,31,32,59,20,19,5,26,27,"g5149",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"72",92,325,581,131,166,249,79,493,438,115,204,281,117,314,552,70,113,282,"g6857","Q1EHB4",2.12e-132,"SC5AC_HUMAN","reviewed","Sodium-coupled monocarboxylate transporter 2 (Electroneutral sodium monocarboxylate cotransporter) (Low-affinity sodium-lactate cotransporter) (Solute carrier family 5 member 12)","SLC5A12 SMCT2","Homo sapiens (Human)",618,"ion transport [GO:0006811]","apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]","apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; lactate transmembrane transporter activity [GO:0015129]; organic acid:sodium symporter activity [GO:0005343]; ion transport [GO:0006811]","lactate transmembrane transporter activity [GO:0015129]; organic acid:sodium symporter activity [GO:0005343]","GO:0005343; GO:0005886; GO:0006811; GO:0015129; GO:0016021; GO:0016324; GO:0070062","K14388;","hsa:159963;"
"73",139,4,9,141,100,12,126,3,28,77,89,21,224,7,22,121,124,7,"g8812","Q9QY53",2.16e-80,"NPHP1_MOUSE","reviewed","Nephrocystin-1","Nphp1 Nph1","Mus musculus (Mouse)",687,"cell projection organization [GO:0030030]; cellular protein localization [GO:0034613]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of bicellular tight junction assembly [GO:1903348]; retina development in camera-type eye [GO:0060041]; spermatid differentiation [GO:0048515]","adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; ciliary base [GO:0097546]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; photoreceptor connecting cilium [GO:0032391]; photoreceptor distal connecting cilium [GO:0120206]","adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; ciliary base [GO:0097546]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; photoreceptor connecting cilium [GO:0032391]; photoreceptor distal connecting cilium [GO:0120206]; cell projection organization [GO:0030030]; cellular protein localization [GO:0034613]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of bicellular tight junction assembly [GO:1903348]; retina development in camera-type eye [GO:0060041]; spermatid differentiation [GO:0048515]","","GO:0005737; GO:0005856; GO:0005911; GO:0005912; GO:0005923; GO:0030030; GO:0031514; GO:0032391; GO:0034613; GO:0035845; GO:0035869; GO:0048515; GO:0060041; GO:0097546; GO:0120206; GO:1903348","K19657;","mmu:53885;"
"74",66,181,98,93,115,41,45,55,55,98,82,65,43,2,42,88,88,5,"g9653","P29174",9.31e-16,"CSDE1_CAVPO","reviewed","Cold shock domain-containing protein E1 (Protein UNR) (Fragment)","CSDE1 UNR","Cavia porcellus (Guinea pig)",114,"","cytoplasm [GO:0005737]","cytoplasm [GO:0005737]; RNA binding [GO:0003723]","RNA binding [GO:0003723]","GO:0003723; GO:0005737","",""
"75",131,352,426,464,217,208,1304,1404,1713,828,1719,1550,2153,1601,1529,425,915,1175,"g10192","Q24180",2.23e-17,"DEAF1_DROME","reviewed","Deformed epidermal autoregulatory factor 1 (Protein DEAF-1)","Deaf1 CG8567","Drosophila melanogaster (Fruit fly)",576,"embryo development ending in birth or egg hatching [GO:0009792]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of immune response [GO:0050776]; regulation of transcription by RNA polymerase II [GO:0006357]","nucleus [GO:0005634]; polytene chromosome [GO:0005700]","nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; embryo development ending in birth or egg hatching [GO:0009792]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of immune response [GO:0050776]; regulation of transcription by RNA polymerase II [GO:0006357]","DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]","GO:0003700; GO:0005634; GO:0005700; GO:0006357; GO:0009792; GO:0043565; GO:0045893; GO:0046872; GO:0050776","K23041;","dme:Dmel_CG8567;"
"76",117,57,20,173,212,17,74,27,25,98,131,0,127,27,16,105,188,9,"g11437","Q6YI48",7.27e-06,"PTPRU_CHICK","reviewed","Receptor-type tyrosine-protein phosphatase U (R-PTP-U) (EC 3.1.3.48) (Receptor-type protein-tyrosine phosphatase psi) (R-PTP-psi) (cRPTPPSI)","PTPRU RPTPPSI","Gallus gallus (Chicken)",1434,"cell adhesion [GO:0007155]; cell differentiation [GO:0030154]","cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]","cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein tyrosine phosphatase activity [GO:0004725]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]","protein tyrosine phosphatase activity [GO:0004725]","GO:0004725; GO:0005886; GO:0007155; GO:0016021; GO:0030054; GO:0030154","K16662;","gga:395153;"
"77",73,241,192,63,62,179,32,239,213,29,113,258,51,224,150,11,31,128,"g11632","P43690",0,"DRG1_XENLA","reviewed","Developmentally-regulated GTP-binding protein 1 (DRG-1) (xDRG) (Translation factor GTPase DRG1) (TRAFAC GTPase DRG1) (EC 3.6.5.-)","drg1 drg","Xenopus laevis (African clawed frog)",367,"microtubule bundle formation [GO:0001578]; positive regulation of microtubule polymerization [GO:0031116]","cytoplasm [GO:0005737]; nucleus [GO:0005634]","cytoplasm [GO:0005737]; nucleus [GO:0005634]; GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; microtubule bundle formation [GO:0001578]; positive regulation of microtubule polymerization [GO:0031116]","GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]","GO:0001578; GO:0005525; GO:0005634; GO:0005737; GO:0008017; GO:0016787; GO:0031116; GO:0046872","","xla:399253;"
"78",321,127,78,597,219,78,209,253,153,333,332,165,408,139,58,171,316,139,"g12347","Q9Y2I7",3.06e-114,"FYV1_HUMAN","reviewed","1-phosphatidylinositol 3-phosphate 5-kinase (Phosphatidylinositol 3-phosphate 5-kinase) (EC 2.7.1.150) (FYVE finger-containing phosphoinositide kinase) (PIKfyve) (Phosphatidylinositol 3-phosphate 5-kinase type III) (PIPkin-III) (Type III PIP kinase)","PIKFYVE KIAA0981 PIP5K3","Homo sapiens (Human)",2098,"intracellular signal transduction [GO:0035556]; myelin assembly [GO:0032288]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; protein localization to nucleus [GO:0034504]; regulation of autophagosome assembly [GO:2000785]; retrograde transport, endosome to Golgi [GO:0042147]","cell-cell junction [GO:0005911]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; vesicle membrane [GO:0012506]","cell-cell junction [GO:0005911]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; vesicle membrane [GO:0012506]; 1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; zinc ion binding [GO:0008270]; intracellular signal transduction [GO:0035556]; myelin assembly [GO:0032288]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; protein localization to nucleus [GO:0034504]; regulation of autophagosome assembly [GO:2000785]; retrograde transport, endosome to Golgi [GO:0042147]","1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; zinc ion binding [GO:0008270]","GO:0000139; GO:0000285; GO:0005524; GO:0005829; GO:0005911; GO:0006661; GO:0008270; GO:0010008; GO:0012506; GO:0016308; GO:0031901; GO:0031902; GO:0032288; GO:0034504; GO:0035556; GO:0042147; GO:0043231; GO:0043813; GO:0045121; GO:0048471; GO:1904562; GO:2000785","K00921;","hsa:200576;"
"79",167,99,144,525,257,167,122,129,55,223,266,136,152,66,89,234,242,72,"g12349","Q8C0Y0",0,"PP4R4_MOUSE","reviewed","Serine/threonine-protein phosphatase 4 regulatory subunit 4","Ppp4r4 Kiaa1622 Pp4r4","Mus musculus (Mouse)",875,"blastocyst hatching [GO:0001835]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; regulation of protein serine/threonine phosphatase activity [GO:0080163]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein serine/threonine phosphatase complex [GO:0008287]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein serine/threonine phosphatase complex [GO:0008287]; protein phosphatase regulator activity [GO:0019888]; blastocyst hatching [GO:0001835]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; regulation of protein serine/threonine phosphatase activity [GO:0080163]","protein phosphatase regulator activity [GO:0019888]","GO:0001835; GO:0005737; GO:0005829; GO:0008287; GO:0019888; GO:0032515; GO:0080163","K15426;","mmu:74521;"
"80",70,30,23,370,121,36,56,61,13,260,197,49,105,24,14,138,223,41,"g12350","Q8UVC3",0,"INVS_CHICK","reviewed","Inversin","INVS","Gallus gallus (Chicken)",1106,"multicellular organism development [GO:0007275]; Wnt signaling pathway [GO:0016055]","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; calmodulin binding [GO:0005516]; multicellular organism development [GO:0007275]; Wnt signaling pathway [GO:0016055]","calmodulin binding [GO:0005516]","GO:0005516; GO:0005737; GO:0005856; GO:0007275; GO:0016055","K19626;","gga:395234;"
"81",82,10,4,10,68,9,75,16,4,14,106,8,73,5,0,17,99,7,"g12681",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"82",38,122,112,39,8,63,8,215,114,28,16,103,4,148,173,10,12,124,"g12748",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"83",94,139,203,177,88,135,121,253,325,149,228,177,234,177,237,123,185,212,"g13104","Q08D62",7.39e-53,"MAEL_XENTR","reviewed","Protein maelstrom homolog","mael","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)",415,"cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; male meiotic nuclear division [GO:0007140]; multicellular organism development [GO:0007275]; negative regulation of transcription, DNA-templated [GO:0045892]; piRNA metabolic process [GO:0034587]; regulation of gene silencing by miRNA [GO:0060964]; spermatogenesis [GO:0007283]","cytoplasm [GO:0005737]; nucleus [GO:0005634]; P granule [GO:0043186]; piP-body [GO:0071547]","cytoplasm [GO:0005737]; nucleus [GO:0005634]; P granule [GO:0043186]; piP-body [GO:0071547]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; male meiotic nuclear division [GO:0007140]; multicellular organism development [GO:0007275]; negative regulation of transcription, DNA-templated [GO:0045892]; piRNA metabolic process [GO:0034587]; regulation of gene silencing by miRNA [GO:0060964]; spermatogenesis [GO:0007283]","sequence-specific DNA binding [GO:0043565]","GO:0005634; GO:0005737; GO:0007140; GO:0007275; GO:0007283; GO:0030154; GO:0031047; GO:0034587; GO:0043046; GO:0043186; GO:0043565; GO:0045892; GO:0060964; GO:0071547","K18411;","xtr:780102;"
"84",3,11,33,10,6,12,162,43,34,33,27,23,135,25,21,9,16,45,"g14108","Q9FMP5",5.13e-06,"CDPKH_ARATH","reviewed","Calcium-dependent protein kinase 17 (EC 2.7.11.1)","CPK17 At5g12180 MXC9.14","Arabidopsis thaliana (Mouse-ear cress)",528,"intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; regulation of pollen tube growth [GO:0080092]","cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]","cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; regulation of pollen tube growth [GO:0080092]","ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; protein serine/threonine kinase activity [GO:0004674]","GO:0004674; GO:0005509; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0009931; GO:0018105; GO:0035556; GO:0046777; GO:0080092","K13412;","ath:AT5G12180;"
"85",297,305,776,535,343,383,285,498,644,379,413,466,166,199,388,123,247,281,"g14555","Q63081",0,"PDIA6_RAT","reviewed","Protein disulfide-isomerase A6 (EC 5.3.4.1) (Calcium-binding protein 1) (CaBP1) (Protein disulfide isomerase P5) (Thioredoxin domain-containing protein 7)","Pdia6 Cabp1 Txndc7","Rattus norvegicus (Rat)",440,"cell redox homeostasis [GO:0045454]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]","cell [GO:0005623]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]","cell [GO:0005623]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular space [GO:0005615]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; calcium ion binding [GO:0005509]; enzyme inhibitor activity [GO:0004857]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]","calcium ion binding [GO:0005509]; enzyme inhibitor activity [GO:0004857]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]","GO:0003756; GO:0004857; GO:0005509; GO:0005615; GO:0005623; GO:0005788; GO:0005790; GO:0005793; GO:0005886; GO:0006457; GO:0015037; GO:0030168; GO:0034663; GO:0042470; GO:0045454; GO:0070527; GO:1903895","K09584;","rno:286906;"
"86",177,302,419,287,97,201,116,451,460,225,149,340,120,285,424,87,126,297,"g16585","O08585",9.68e-42,"CLCA_MOUSE","reviewed","Clathrin light chain A (Lca)","Clta","Mus musculus (Mouse)",235,"cell cycle [GO:0007049]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]","clathrin coat [GO:0030118]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin vesicle coat [GO:0030125]; cytoplasmic vesicle [GO:0031410]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic endocytic zone [GO:0098843]; postsynaptic endocytic zone cytoplasmic component [GO:0099631]; presynaptic endocytic zone membrane [GO:0098835]; spindle [GO:0005819]; synaptic vesicle membrane [GO:0030672]","clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin vesicle coat [GO:0030125]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle [GO:0031410]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic endocytic zone [GO:0098843]; postsynaptic endocytic zone cytoplasmic component [GO:0099631]; presynaptic endocytic zone membrane [GO:0098835]; spindle [GO:0005819]; synaptic vesicle membrane [GO:0030672]; clathrin heavy chain binding [GO:0032050]; GTPase binding [GO:0051020]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]; cell cycle [GO:0007049]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]","clathrin heavy chain binding [GO:0032050]; GTPase binding [GO:0051020]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]","GO:0005198; GO:0005819; GO:0005886; GO:0005905; GO:0006886; GO:0007049; GO:0030118; GO:0030125; GO:0030130; GO:0030132; GO:0030136; GO:0030672; GO:0031410; GO:0032050; GO:0042277; GO:0044877; GO:0048268; GO:0051020; GO:0051301; GO:0071439; GO:0072583; GO:0098835; GO:0098843; GO:0098978; GO:0099631","",""
"87",1173,1994,1610,1636,1752,4896,475,1331,577,452,747,1547,127,264,140,115,144,246,"g17141","P97784",1.12e-164,"CRY1_MOUSE","reviewed","Cryptochrome-1","Cry1","Mus musculus (Mouse)",606,"circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA damage induced protein phosphorylation [GO:0006975]; entrainment of circadian clock by photoperiod [GO:0043153]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; lipid storage [GO:0019915]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of glucocorticoid secretion [GO:2000850]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein ubiquitination [GO:0031398]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; regulation of DNA damage checkpoint [GO:2000001]; response to activity [GO:0014823]; response to glucagon [GO:0033762]; response to insulin [GO:0032868]; response to light stimulus [GO:0009416]","cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]","cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; E-box binding [GO:0070888]; histone deacetylase binding [GO:0042826]; kinase binding [GO:0019900]; nuclear hormone receptor binding [GO:0035257]; nucleotide binding [GO:0000166]; phosphatase binding [GO:0019902]; photoreceptor activity [GO:0009881]; protein kinase binding [GO:0019901]; transcription factor binding [GO:0008134]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA damage induced protein phosphorylation [GO:0006975]; entrainment of circadian clock by photoperiod [GO:0043153]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; lipid storage [GO:0019915]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of glucocorticoid secretion [GO:2000850]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of protein ubiquitination [GO:0031398]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; regulation of DNA damage checkpoint [GO:2000001]; response to activity [GO:0014823]; response to glucagon [GO:0033762]; response to insulin [GO:0032868]; response to light stimulus [GO:0009416]","double-stranded DNA binding [GO:0003690]; E-box binding [GO:0070888]; histone deacetylase binding [GO:0042826]; kinase binding [GO:0019900]; nuclear hormone receptor binding [GO:0035257]; nucleotide binding [GO:0000166]; phosphatase binding [GO:0019902]; photoreceptor activity [GO:0009881]; protein kinase binding [GO:0019901]; transcription factor binding [GO:0008134]","GO:0000122; GO:0000166; GO:0003690; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0006094; GO:0006975; GO:0007623; GO:0008134; GO:0009416; GO:0009881; GO:0014823; GO:0018298; GO:0019900; GO:0019901; GO:0019902; GO:0019915; GO:0031397; GO:0031398; GO:0032868; GO:0032922; GO:0033762; GO:0035257; GO:0042593; GO:0042752; GO:0042754; GO:0042826; GO:0043153; GO:0045721; GO:0045744; GO:0045892; GO:0070888; GO:2000001; GO:2000323; GO:2000850","K02295;","mmu:12952;"
"88",5,14,38,38,10,22,39,37,43,88,49,39,40,39,34,55,90,52,"g17638","P51029",7.56e-74,"WNT8B_DANRE","reviewed","Protein Wnt-8b","wnt8b wnt-8b","Danio rerio (Zebrafish) (Brachydanio rerio)",358,"canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; commissural neuron axon guidance [GO:0071679]; embryonic pattern specification [GO:0009880]; eye development [GO:0001654]; eye field cell fate commitment involved in camera-type eye formation [GO:0060898]; forebrain development [GO:0030900]; forebrain neuron differentiation [GO:0021879]; hypothalamus development [GO:0021854]; negative regulation of anterior neural cell fate commitment of the neural plate by Wnt signaling pathway [GO:0022002]; neuron differentiation [GO:0030182]; otic placode formation [GO:0043049]; sensory epithelium regeneration [GO:0070654]; Wnt signaling pathway [GO:0016055]","extracellular space [GO:0005615]","extracellular space [GO:0005615]; frizzled binding [GO:0005109]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; commissural neuron axon guidance [GO:0071679]; embryonic pattern specification [GO:0009880]; eye development [GO:0001654]; eye field cell fate commitment involved in camera-type eye formation [GO:0060898]; forebrain development [GO:0030900]; forebrain neuron differentiation [GO:0021879]; hypothalamus development [GO:0021854]; negative regulation of anterior neural cell fate commitment of the neural plate by Wnt signaling pathway [GO:0022002]; neuron differentiation [GO:0030182]; otic placode formation [GO:0043049]; sensory epithelium regeneration [GO:0070654]; Wnt signaling pathway [GO:0016055]","frizzled binding [GO:0005109]","GO:0001654; GO:0005109; GO:0005615; GO:0009880; GO:0016055; GO:0021854; GO:0021879; GO:0022002; GO:0030182; GO:0030900; GO:0043049; GO:0045165; GO:0060070; GO:0060898; GO:0070654; GO:0071679","K00714;","dre:30144;"
"89",20,56,56,28,26,8,75,366,301,139,213,251,1087,1725,2455,747,1133,1894,"g20211","P41224",4.86e-14,"TEF_RAT","reviewed","Thyrotroph embryonic factor","Tef","Rattus norvegicus (Rat)",301,"positive regulation of transcription by RNA polymerase II [GO:0045944]; rhythmic process [GO:0048511]","nucleus [GO:0005634]","nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rhythmic process [GO:0048511]","DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]","GO:0000977; GO:0000978; GO:0001228; GO:0003690; GO:0005634; GO:0042802; GO:0043565; GO:0044877; GO:0045944; GO:0048511","K09058;","rno:29362;"
"90",9,27,18,23,0,14,19,49,51,19,22,28,109,154,191,57,60,84,"g20212",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
